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A B S T R A C T
Background
The Mini Mental State Examination (MMSE) is a cognitive test that is commonly used as part of the evaluation for possible dementia.
Objectives
To determine the diagnostic accuracy of the Mini-Mental State Examination (MMSE) at various cut points for dementia in people
aged 65 years and over in community and primary care settings who had not undergone prior testing for dementia.
Search methods
We searched the specialised register of the Cochrane Dementia and Cognitive Improvement Group, MEDLINE (OvidSP), EMBASE
(OvidSP), PsycINFO (OvidSP), LILACS (BIREME), ALOIS, BIOSIS previews (Thomson Reuters Web of Science), and Web of
Science Core Collection, including the Science Citation Index and the Conference Proceedings Citation Index (Thomson Reuters
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Web of Science). We also searched specialised sources of diagnostic test accuracy studies and reviews: MEDION (Universities of
Maastricht and Leuven, www.mediondatabase.nl), DARE (Database of Abstracts of Reviews of Effects, via the Cochrane Library),
HTA Database (Health Technology Assessment Database, via the Cochrane Library), and ARIF (University of Birmingham, UK,
www.arif.bham.ac.uk). We attempted to locate possibly relevant but unpublished data by contacting researchers in this field. We first
performed the searches in November 2012 and then fully updated them inMay 2014. We did not apply any language or date restrictions
to the electronic searches, and we did not use any methodological filters as a method to restrict the search overall.
Selection criteria
We included studies that compared the 11-item (maximum score 30) MMSE test (at any cut point) in people who had not undergone
prior testing versus a commonly accepted clinical reference standard for all-cause dementia and subtypes (Alzheimer disease dementia,
Lewy body dementia, vascular dementia, frontotemporal dementia). Clinical diagnosis included all-cause (unspecified) dementia, as
defined by any version of the Diagnostic and Statistical Manual of Mental Disorders (DSM); International Classification of Diseases
(ICD) and the Clinical Dementia Rating.
Data collection and analysis
At least three authors screened all citations.Two authors handled data extraction and quality assessment. We performed meta-analysis
using the hierarchical summary receiver-operator curves (HSROC) method and the bivariate method.
Main results
We retrieved 24,310 citations after removal of duplicates. We reviewed the full text of 317 full-text articles and finally included 70
records, referring to 48 studies, in our synthesis. We were able to perform meta-analysis on 28 studies in the community setting (44
articles) and on 6 studies in primary care (8 articles), but we could not extract usable 2 x 2 data for the remaining 14 community
studies, which we did not include in the meta-analysis. All of the studies in the community were in asymptomatic people, whereas two
of the six studies in primary care were conducted in people who had symptoms of possible dementia. We judged two studies to be at
high risk of bias in the patient selection domain, three studies to be at high risk of bias in the index test domain and nine studies to
be at high risk of bias regarding flow and timing. We assessed most studies as being applicable to the review question though we had
concerns about selection of participants in six studies and target condition in one study.
The accuracy of theMMSE for diagnosing dementia was reported at 18 cut points in the community (MMSE score 10, 14-30 inclusive)
and 10 cut points in primary care (MMSE score 17-26 inclusive). The total number of participants in studies included in the meta-
analyses ranged from 37 to 2727, median 314 (interquartile range (IQR) 160 to 647). In the community, the pooled accuracy at a cut
point of 24 (15 studies) was sensitivity 0.85 (95% confidence interval (CI) 0.74 to 0.92), specificity 0.90 (95% CI 0.82 to 0.95); at
a cut point of 25 (10 studies), sensitivity 0.87 (95% CI 0.78 to 0.93), specificity 0.82 (95% CI 0.65 to 0.92); and in seven studies
that adjusted accuracy estimates for level of education, sensitivity 0.97 (95% CI 0.83 to 1.00), specificity 0.70 (95% CI 0.50 to 0.85).
There was insufficient data to evaluate the accuracy of the MMSE for diagnosing dementia subtypes.We could not estimate summary
diagnostic accuracy in primary care due to insufficient data.
Authors’ conclusions
The MMSE contributes to a diagnosis of dementia in low prevalence settings, but should not be used in isolation to confirm or exclude
disease. We recommend that future work evaluates the diagnostic accuracy of tests in the context of the diagnostic pathway experienced
by the patient and that investigators report how undergoing the MMSE changes patient-relevant outcomes.
P L A I N L A N G U A G E S U M M A R Y
Mini-Mental State Examination (MMSE) for the detection of dementia in people aged over 65
The term ’dementia’ covers a group of brain problems that cause gradual deterioration of brain function, thinking skills, and ability to
perform everyday tasks (e.g. washing and dressing). People with dementia may also develop problems with their mental health (mood
and emotions) and behaviour that are difficult for other people to manage or deal with. The process that causes dementia in the brain
is often degenerative (due to brain damage over time). Subtypes of dementia include Alzheimer’s disease dementia, vascular dementia,
dementia with Lewy bodies and frontotemporal dementia.
We aimed to assess the accuracy of the Mini-Mental State Examination (MMSE), which is commonly used as part of the process when
considering a diagnosis of dementia, according to the definition in the Diagnostic and Statistical Manual of Mental Disorders (DSM).
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The MMSE is a paper-based test with a maximum score of 30, with lower scores indicating more severe cognitive problems. The
cut point established for the MMSE defines ’normal’ cognitive function and is usually set at 24, although theoretically it could fall
anywhere from 1 to 30. We searched a wide range of resources and found 24,310 unique citations (hits). We reviewed the full text of
317 academic papers and finally included 70 articles, referring to 48 studies in our review. We included community studies (by which
we mean people living in the community who have ) and primary care studies (by which we mean studies that had an office-based first
contact care with a non specialist clinician - which would often be a GP).
Two of the studies had serious design weaknesses with regard to their methods for selecting participants, three with regard to the
application of the test (MMSE), and nine with regard to the presentation of flow and timing. We were able to do a combined statistical
analysis (meta-analysis) on 28 studies in the community setting (44 articles) and 6 studies in primary care (8 articles), but we could
not extract usable data for the remaining 14 community studies. Two of the six studies in primary care were conducted in people who
had symptoms of possible dementia. We were able to calculate the summary diagnostic accuracy of the MMSE at three cut points in
community-based studies, but we didn’t have enough data to do this in the primary care studies. A perfect test would have sensitivity
(ability to identify anyone with dementia) of 1.0 (100%) and specificity (ability to identify people without dementia) of 1.0 (100%).
For the MMSE, the summary accuracy at a cut point of 25 (10 studies) was sensitivity 0.87 and specificity 0.82. In seven studies that
adjusted accuracy estimates for level of education, we found that the test had a sensitivity of 0.97 and specificity of 0.70. The summary
accuracy at a cut point of 24 (15 studies) was sensitivity 0.85 and specificity 0.90. Based on these results, we would expect 85% of
people with dementia to be correctly identified with the MMSE, while 15% would be wrongly classified as not having dementia; 90%
of those tested would be correctly identified as not having dementia whilst 10% would be false positives and might be referred for
further testing.
Our results support the use of the MMSE as part of the process for deciding whether or not someone has dementia, but the results
of the test should be interpreted in broader context of the individual patient, such as their personality, behaviour and how they are
managing at home and in daily life.
B A C K G R O U N D
The protocol for this review was based on ’Neuropsychological
tests for the diagnosis of Alzheimer’s disease dementia and other
dementias: a generic protocol for cross-sectional and delayed-ver-
ification studies’ (Davis 2013a). This review forms part of a suite
of reviews that address the accuracy of different neuropsycholog-
ical tests for the cross-sectional and delayed-verification diagnosis
of dementia in a range of populations, for example the the Mon-
treal Cognitive Assessment for the diagnosis of Alzheimer’s dis-
ease and other dementia disorders (Davis 2013b), the Informant
Questionnaire on Cognitive Decline in the Elderly (IQCODE)
for the diagnosis of Alzheimer’s disease dementia and other de-
mentias within a general practice (primary care) setting (Quinn
2013); Mini-Cog for the diagnosis of Alzheimer’s disease demen-
tia and other dementias within a community setting (Fage 2013)
and Mini-Mental State Examination (MMSE) for the detection
of Alzheimer’s disease and other dementias in people with mild
cognitive impairment (Arevalo-Rodriguez 2013).
This review addresses the use of the Mini-Mental State Exam-
ination (MMSE) for the cross-sectional (current) diagnosis of
Alzheimer’s dementia and other dementias when used in the com-
munity and primary care, which are populations with a relatively
low prevalence of dementia (approximately 7%; Matthews 2013)
compared to memory clinics (around 60%; Banerjee 2007) and
secondary or inpatient care. We included studies that examine the
accuracy of the MMSE in previously unevaluated people with or
without symptoms (akin to screening) because we aimed to address
the accuracy of the MMSE when applied to the clinically relevant
question of patients and clinicians, ’Does this person have demen-
tia now?’. A separate review evaluates the accuracy of the MMSE
for delayed verification of dementia diagnosis at some future point
(addressing the question, ’Is the current level of cognition suffi-
ciently poor that this person has a pre-dementia syndrome?’).
Target condition being diagnosed
Dementia is a progressive syndrome of global cognitive impair-
ment that affects 6.5% of the UK population aged over 65 years
(Matthews 2013). There is a significant global disease burden (36
million patients worldwide) that is predicted to increase to over
115 million by 2050, particularly in developing regions (Ferri
2005; Wimo 2010). Dementia encompasses a group of neurode-
generative disorders that are characterised by a progressive loss of
cognitive function and ability to perform activities of daily living
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that can be accompanied by neuropsychiatric symptoms and chal-
lenging behaviours of varying type and severity. Prior ability is also
important: someone could have a decline in their cognition over
time andmeet criteria for a diagnosis of dementiawhile still scoring
above average on a cognitive test. The underlying pathology is usu-
ally degenerative, and subtypes of dementia include Alzheimer’s
disease dementia, vascular dementia, dementia with Lewy bodies
(pathological clusters of alpha-synuclein protein; McKeith 2005),
and frontotemporal dementia. There is considerable overlap in the
clinical and pathological presentations; for example, Alzheimer’s
disease pathologymay be present in peoplewhohave a clinical phe-
notype of vascular or Lewy body dementia, and vascular changes
and Lewy bodies are common in the postmortem examination
of brains of people with an Alzheimer’s disease phenotype (CFAS
2001; Matthews 2009; Savva 2009). Some commentators have
therefore advised against the use of neuropathological criteria as
the gold standard for the diagnosis of dementia, including sub-
types (Scheltens 2011).
The target condition in this review will be dementia or its subtypes
(as defined by the reference standards described below), identified
simultaneously with the administration of the index test.
Index test(s)
The Folstein Mini-Mental State Examination (MMSE) is an 11-
item assessment of cognitive function that assesses attention and
orientation,memory, registration, recall, calculation, language and
ability to draw a complex polygon (Folstein 1975). The MMSE
is subject to copyright restrictions (De Silva 2010), and it takes
around sevenminutes to administer to a personwith dementia and
five minutes to a person with normal cognition (Borson 2000).
Scores can range from 1 to 30; the conventional cut-off is 24, with
lower scores indicating increasing cognitive impairment (Mitchell
2009), although other cut-off points have been suggested (Crum
1993; Kukull 1994). There is a wide spectrum in the severity of
disease that people with dementia have, and this will affect the
diagnostic properties of a diagnostic test such as the MMSE.
Clinical pathway
Dementia develops over several years, from a presumed initial
asymptomatic period where pathological changes accumulate in
the absence of clinical manifestations, through subtle impairments
of recent memory or changes in personality or behaviour, until
the disease has become more apparent, with multiple cognitive
domains involved and a noticeable decline from previous abilities
in planning and performing complex tasks.
Standard diagnostic practice
Standard diagnostic assessment relates to evaluating people for
whom there is concern about possible dementia, particularly to
exclude alternative diagnostic hypotheses, and it includes history,
clinical examination (includingneurological,mental state and cog-
nitive examination) and an interview with a relative or other in-
formant. Before diagnosing dementia, other physical and mental
disorders that might be contributing to cognitive impairment, for
example hypothyroidism or depression, should be identified and
if possible treated. Most recent guidelines recommend a neuro-
radiological examination to scan the brain (Computed Tomog-
raphy (CT) or Magnetic Resonance Imaging (MRI)) to exclude
structural causes for the clinical phenotype, for example a subdural
haematoma (McKhann 2011; NICE 2006), but sometimes clin-
icians make the diagnosis on the history and presentation alone.
Dementia diagnosis is defined by a deficit in more than two cog-
nitive domains of sufficient degree to impair functional activities.
These symptoms are usually progressive over a period of at least
several months and should not be attributable to any other brain
disorder. The International Classification of Diseases, 10th edi-
tion (ICD-10) and the Diagnostic and Statistical Manual of Men-
tal Disorders (DSM) general diagnostic criteria for dementia are
detailed in Appendix 1 (APA 1994; WHO 1992).
Screening
Screening is the identification of unrecognised or asymptomatic
disease by the administration of tests that can be applied quickly
and are not intended to be diagnostic (Porta 2008). Recent UK
health policy has encouraged opportunistic testing of older people
attending primary care who have presented for reasons other than
amemory complaint (Brunet 2012; Le Couteur 2013; Rasmussen
2013). GPs in the UK are encouraged to actively find people with
dementia through routine annual questions in a Direct Enhanced
Service (DOH recommendations; NICE 2013). In some cases,
after further evaluation, the GP may then make a diagnosis of
dementia, with or without a subtype (Ahmad 2010). Dementia
screening is not recommended by the United States Preventive
Services Task Force (US Preventive Services 2003), but the Patient
Protection and Affordable Care Act requires an annual assessment
of cognition for people who are enrolled in Medicare (Cordell
2013). The UK government has also encouraged case finding for
dementia on acute admission to secondary care services (Dementia
CQUIN).
Because people with dementia may not experience subjective
memory problems, and a diagnosis of dementia often requires di-
agnostic evaluation by an experienced clinician, triage tests such
as the MMSE are used in clinical practice to help rapidly identify
people with a high likelihood of having normal cognition who do
not require onward referral and investigation. Some investigations
have blurred the distinction between the use of tests as a screening
instrument in individuals without manifest disease and their use
as clinical triage tools (Kamenski 2009).
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Presentation to health services
In the UK people with memory problems usually present initially
to their primary care practitioner, whomay administer theMMSE
to ’rule in’ or confirm the possibility of dementia and potentially
refer the patient to a specialist hospital memory clinic. Some peo-
ple with dementia present much later in the disorder or follow a
different pathway to diagnosis, for example, during an admission
to general hospital for a physical illness. Diagnostic assessment
pathways may vary in other countries, and a variety of clinicians
including neurologists, psychiatrists and geriatricians, may make
the diagnoses.
Role of the index test
Many countries in Europe and worldwide have been developing
dementia strategies that emphasise the importance of accurate di-
agnosis to access appropriate health and social care services. De-
spite copyright restrictions, current experience is that the MMSE
is still used extensively in clinical practice (Su 2014), including in
the primary care setting, where clinicians may use it as either a
screening test for dementia or as part of a more detailed evaluation
of a person with suspected dementia. In some people, for example
those who are particularly frail or unable to travel to a specialist
clinic, theMMSEmay be the only cognitive test used as part of the
evaluation for possible dementia. A systematic evaluation of the
diagnostic test accuracy of the instrument is needed to determine
what confidence patients and clinicians can have in the clinical
diagnosis of dementia based on the MMSE. A confirmed diag-
nosis of dementia is believed to offer opportunities for interven-
tions, both social and medical, which may reduce the associated
behavioural and psychiatric symptoms of dementia (Birks 2006;
Clare 2003; McShane 2006), helping people with dementia, their
families and potential caregivers to plan and avoid admissions to
hospital or institutional care (Bourne 2007).
Prior tests
We anticipated the likelihood that no prior tests would have been
performed before evaluating patients. In some settings, a two-stage
screening and assessment process takes place. Screening of people
with suspected dementia usually requires a brief test of cognitive
function, informant questionnaires or both, with a low score in-
dicating a need for more in-depth assessment (Boustani 2003).
We anticipated that some studies carried out in the community
and in primary care may have administered a very brief, high sen-
sitivity instrument before applying the MMSE and investigating
all of those who screened positive and a subsample of those who
screened negative. In this eventuality, we planned to include the
study and consider the prior test as a potential source of hetero-
geneity. However, no study used a test prior to the MMSE. Other
tests are available to screen for dementia in primary care (Tsoi
2015), but we limited our review to the MMSE.
Rationale
Policy for dementia diagnosis is developing rapidly and has
changed since the publication of the generic protocol for neu-
ropsychological tests (Davis 2013a). There is a great need for a sys-
tematic appraisal of the diagnostic accuracy of neuropsychological
tests, including the MMSE, in unselected (clinically unevaluated)
populations.
O B J E C T I V E S
To determine the diagnostic accuracy of the Mini-Mental State
Examination (MMSE) at various cut points for dementia in people
aged 65 years and over in community and primary care settings
who had not undergone prior testing for dementia.
Secondary objectives
To investigate the heterogeneity of test accuracy in the included
studies.We anticipated that there would bemany potential sources
of heterogeneity in this review, which Davis 2013a covered fully.
In this review we expected that the most important sources of het-
erogeneity would be the characteristics of the study populations,
the way investigators used the MMSE and the reference standard
employed.
M E T H O D S
Criteria for considering studies for this review
Types of studies
The inclusion criteria for studies in this review were based on the
generic protocol for neuropsychological tests in dementia (Davis
2013a). We reviewed the diagnostic accuracy of the MMSE when
used in people aged over 65 years in non-specialist settings, includ-
ing community settings (population-based screening) and primary
care settings (where people may be screened opportunistically or
present to the primary care practitioner with memory problems).
We included studies that examined the diagnostic accuracy of the
MMSE in people considered to have a memory problem (by pa-
tient, informant or clinician), as well as screening studies that ex-
amined the diagnostic accuracy in people regardless of a memory
complaint (asymptomatic people). We analysed studies separately
based on whether they were screening studies or not, as described
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in Investigations of heterogeneity. We included a diagnosis of de-
mentia at any stage of disease (as long as the dementia was not pre-
viously identified by a specialist), as we considered that this prag-
matic approach was most likely to be useful in informing current
health policy and clinical practice. We did not examine the accu-
racy of MMSE for the diagnosis of pre-clinical dementia (Sperling
2011), as this will be the subject of a separate review.
We included cross-sectional studies that administered the index
test and the reference standard(s)within a short time span (less than
six months). We excluded case-control studies because of the risk
of bias (Whiting 2013). We did not include delayed verification
studies, as these will be examined in a separate review, as described
in the Background. We included studies where we anticipated 2 x
2 data would be available even if it was not reported in the original
paper, and we contacted the authors to obtain it where necessary.
Figure 1 outlines the process that we used for including articles in
the review; further details are given in Selection of studies.
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Figure 1. Inclusion of studies
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Participants
We included all participants who met the criteria for inclusion in
community-based or primary care described above. We defined
primary care as non-specialist, office-based care with a first-con-
tact healthcare provider. We excluded studies where the MMSE
was administered in a secondary care population, for example an
emergency department, neurology ward or memory clinic.
We excluded studies of participants with previous or current
substance abuse, central nervous system trauma (e.g. subdural
haematoma), tumour or infection. Similarly, we excluded studies
that recruited participants solely on the basis of disease state (for
example; Parkinson’s disease, multiple sclerosis, brain injury, mo-
tor neurone disease) or residence (for example; residential home,
nursing home, prison), as they are not applicable to the general
population. We considered that studies that recruited participants
conditional on these criteria would have a different prevalence of
dementia than the general population. We included studies that
recruited participants from retirement communities (defined as
non-nursing elderly person independent facilitated living com-
munities but not residential homes where multiple elderly people
from different families lived in a single building with resident car-
ers), as we considered that residents in these settings are likely to
be similar to the population in terms of cognition and co-mor-
bidities.
Our intention was that the findings of this review would have rel-
evance to clinicians in community health and primary care, and
be applicable to people with ’usual dementia’ (Brayne 2012). We
therefore excluded studies that investigated specific clinical groups.
For example, participants with a family history of Alzheimer’s de-
mentia may be more readily diagnosed with dementia, perhaps
leading to verification bias. On this basis, we excluded studies that
exclusively investigated people with a known genetic predisposi-
tion from this review and studies specifically investigating early-
onset dementia.
Examples of applicable studies for this review include the follow-
ing.
• Participants selected regardless of suspicion of cognitive
disorder. This would be an unselected cross-sectional survey that
administered the MMSE to all participants and then evaluated
all participants (or a random sample), regardless of MMSE
result, with a full assessment for the presence or absence of the
target disorder. These studies are analogous to screening and
could be conducted in:
• ◦ the community;
◦ people attending primary care, as defined in
Participants section, though we considered these studies would
be uncommon as they would involve screening people for
cognitive disorder in a doctor’s office waiting room, and the
ethics of this are not established.
• Participants selected as being suspected of having cognitive
disorder. These studies could be conducted in:
◦ the community, though we anticipated these studies
would be uncommon, as many people who are suspected of
having cognitive disorder will seek evaluation in a healthcare
setting;
◦ primary care.
Thus, we anticipated that we might find studies using the MMSE
in two different ways (evaluating people with and without suspi-
cion of cognitive disorder) in two different clinical settings (com-
munity, before seeking diagnostic evaluation; and primary care, at
the point of seeking diagnostic evaluation). We expected the diag-
nostic accuracy of the MMSE to differ between studies based in
community and in primary care populations (and particularly in
primary care participants selected on the basis of memory symp-
toms), and we planned to conduct separate analyses in these four
potential study populations if appropriate.
Index tests
The index test is the 11-item (maximum score 30) MMSE test
(Folstein 1975). We recognised that other versions of the test exist
(Grace 1995; Harrell 2000; Haubois 2012; Kabir 2000; Molloy
1991; Tschanz 2002), but we considered that these were best inves-
tigated in separate studies because of the substantial heterogeneity
in the diagnostic test performance of these instruments. We also
judged that including these index test variants would create an
unfeasible workload for this review. However, we did not exclude
studies on the basis of language, and we included studies that re-
ported, for example, the diagnostic test accuracy of the Korean
version of the 11-item MMSE. Because education is associated
with dementia (Fratiglioni 1991), some studies adjust the MMSE
score for educational attainment (e.g. Liu 1996a).
Target conditions
The target condition was all-cause dementia and any dementia
subtype. We expected to find studies that focused on all-cause
dementia, Alzheimer disease dementia, vascular dementia, Lewy
body dementia and frontotemporal dementia. We planned to ap-
praise findings separately if we could extract included studies ex-
amining dementias of differing aetiologies or differing stages.
Reference standards
In this review, the target condition was dementia or its subtypes
as defined by the clinical reference standards described in Davis
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2013a and outlined below. We excluded studies that used neu-
ropathological criteria as the only reference standard, as this review
seeks to determine a cross-sectional diagnosis of dementia. Clinical
diagnosis included all-cause (unspecified) dementia, as defined by
any version of the DSM, which when conducting the review was
most recently the fourth edition (APA 1994); any version of ICD,
which when conducting the review was most recently ICD, 10th
edition (WHO 1992) (see Appendix 1); or the Clinical Dementia
Rating (Morris 1993). In studies in which a reference standard
refers to different criteria for dementia (for example McKhann
1984: unlikely, possible, probable, definite), we considered people
as having the disease if they were classified as having either prob-
able or definite dementia.
Alzheimer’s dementia
The National Institute of Neurological and Communicative Dis-
orders and Stroke and the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) have proposed the
best ante-mortem, clinical consensus ’reference standard’ for
Alzheimer’s disease, defining three ante-mortem groups: probable,
possible, and unlikely Alzheimer’s dementia (McKhann 1984).
Newer criteria for Alzheimer’s disease introduced in 2011 in-
clude the use of biomarkers (such as brain imaging and cere-
brospinal fluid analysis) to contribute to diagnostic categories
(McKhann 2011). We planned to present any studies that used
these (biomarker) criteria in a separate category and to test the
findings in a sensitivity analysis.
Lewy body dementia
The reference standard for Lewy body dementia is the McKeith
criteria or their revision (McKeith 1996; McKeith 2005).
Frontotemporal dementia
The reference standard for frontotemporal dementia is the Lund
criteria (Lund 1994).
Vascular dementia
The reference standard for vascular dementia is the National
Institute of Neurological and Communicative Disorders and
Stroke and the Association Internationale pour la Recherché
et l’Enseignement en Neurosciences (NINCDS-AIREN) criteria
(Román 1993).
We recognised that different iterations of reference standards over
time may not be directly comparable (e.g. DSM-III-R versus
DSM-IV, ICD-9 versus ICD-10) and that the validity of diag-
noses may vary with the degree or manner in which the criteria
have been applied (e.g. individual clinician versus algorithm versus
consensus determination). We collected data on the method and
application of the reference standard, and we planned to examine
this as a source of heterogeneity if we considered it to be a source of
bias. Although it is unlikely that a specific reference standardmight
favour particular index tests, there is the more general issue of in-
corporation bias, in which the reference standard is applied with
knowledge of the index test because neuropsychological deficits
are integral to the definition of dementia. This is less problematic
in cross-sectional studies because the index test and the reference
standard may be administered completely independently.
Search methods for identification of studies
Electronic searches
We searched theCochraneDementia andCognitive Improvement
Group’s specialised register (via the Cochrane Register of Stud-
ies); MEDLINE (OvidSP) (January 1946 to May 2014); EM-
BASE (OvidSP) (January 1972 to May 2014); BIOSIS previews
(Thomson Reuters Web of Science) (January 1922 to May 2014);
Web of Science Core Collection, including the Science Citation
Index and the Conference Proceedings Citation Index (Thomson
Reuters Web of Science) (January 1945 to May 2014); PsycINFO
(OvidSP) (January 1806 to May 2014) and LILACS (BIREME).
See Appendix 2 for the search strategies. Where appropriate, we
used controlled vocabulary such as MeSH terms (in MEDLINE)
and EMTREE (in EMBASE) and other controlled vocabulary in
other databases, as appropriate. We did not use search filters de-
signed to retrieve diagnostic test accuracy studies (collections of
terms aimed at reducing the number needed to screen by filtering
out irrelevant records and retaining only those that are relevant)
as a method to restrict the search overall, because available filters
have not yet proved sensitive enough for systematic review searches
(Beynon 2013; Whiting 2011). We did not apply any language
restriction to the electronic searches; we used translation services
as necessary during the screening stages.
A single researcher with extensive experience in systematic reviews
performed the searches. We first performed the searches on 21
November 2012 and then again on 20 May 2014.
Searching other resources
We checked the reference lists of all relevant papers for additional
studies. We also searched:
• Meta-analyses van Diagnostisch Onderzoek (MEDION
database) (www.mediondatabase.nl);
• Database of Abstracts of Reviews of Effects (DARE) (
www.cochranelibrary.com);
• Health Technology Assessments Database (HTA Database)
in The Cochrane Library (www.cochranelibrary.com);
• Aggressive Research Intelligence Facility (ARIF database) (
www.arif.bham.ac.uk).
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We attempted to contact authors where necessary to obtain details
of unpublished studies.
Data collection and analysis
Selection of studies
Figure 1 shows a flowchart that we used when considering whether
to include studies in the review.
The inclusion criteria were:
• population is either community or primary care (see ’Types
of studies’);
• reference standards as described above;
• MMSE was used as an index test (alone or with other tests)
and was administered to all study participants;
• study design is cohort or nested case-control.
Exclusion criteria were:
• classic case-control study design (subject to spectrum bias);
• index test administered to only cases or controls, rather
than to both groups (cannot calculate diagnostic accuracy).
We selected studies based on the title and abstract screening un-
dertaken by a team of trained assessors. Two assessors indepen-
dently reviewed all citations retrieved by the searches and classified
them as relevant or not. Pairs of authors then assessed the full-text
papers of studies classified as possibly relevant, and we resolved
any disagreements by discussion with a third, senior author. We
show the process of study selection in a PRISMA flow diagram in
Figure 2.
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Figure 2. PRISMA Flow diagram of included studies.
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Data extraction and management
Two senior authors simultaneously extracted data on study char-
acteristics and 2 x 2 data directly into Review Manager (RevMan
2014). We resolved disagreements by reaching consensus with a
third, senior author.
Assessment of methodological quality
We assessed the risk of bias of each study using the QUADAS-2
tool in duplicate (Whiting 2011), as recommended by Cochrane
(see Appendix 4 for QUADAS 2 statements and Appendix 5 for
anchoring statements). The ’Assessment of methodological qual-
ity table’ helps the reader to evaluate the strength of evidence to
support the diagnostic accuracy of the MMSE.
Statistical analysis and data synthesis
We expected the diagnostic accuracy of the MMSE to differ be-
tween studies based in community and in primary care settings
(and particularly in primary care participants selected on the basis
of memory symptoms), and we planned to conduct separate anal-
yses in the four potential study populations (see Types of studies
above). We also planned to conduct separate analyses as required
for each subtype of dementia.
For all included studies, the data in the 2 x 2 tables (showing the
binary test results cross-classified with the binary reference stan-
dard) was used to calculate the sensitivities and specificities, with
95% confidence intervals. We present a summary of the included
studies in Table 1 and Table 2. If studies reported more than one
cut point, we presented the findings for all cut points reported.
In our main analysis, we performed meta-analyses on pairs of sen-
sitivity and specificity, stratified by setting (community and pri-
mary care) using the HSROC method, using only one estimate
from each study (Macaskill 2010). Where reported, this was the
standard MMSE cut point of 23/24, where 24 indicates normal
cognition, and where unreported, we used either the only estimate
that was reported, or the best estimate (from the top lefthand cor-
ner of the study ROC curve, acknowledging that this may over-
estimate diagnostic accuracy in that study). We used Stata soft-
ware (Stata) to perform the analysis and used the data to plot the
summary ROC curve. We then used a bivariate random-effects
model approach based on pairs of sensitivity and specificity (Chu
2006; Macaskill 2010; Reitsma 2005) to analyse the diagnostic
accuracy at specific cut points in community-based studies, where
there appeared to be consensus that these were commonly reported
cut points (24 and 25 indicating normal and MMSE adjusted for
education).
Investigations of heterogeneity
We investigated heterogeneity in the first instance through visual
examination of forest plots of sensitivities and specificities.We pre-
specified factors that would potentially contribute to heterogeneity
and attempted to adjust for these in the meta-analysis for average
age of participants (in categories: 65 to 74 years, 75 to 84 years,
85 to 94 years, 95 years or more, unclear), sex, conduct of the test
(in categories: specialist, trained non-specialist, or unclear) and
reference standard. We used likelihood ratio tests to compare the
fit of candidate models when assessing the effect of a covariate on
test performance (Macaskill 2010).
Sensitivity analyses
We planned to perform sensitivity analyses to determine the effect
of excluding studies deemed to be at high risk of bias. However,
as studies were generally at low risk of bias - no study had more
than two of four QUADAS-2 items assessed as having a high risk
of bias - we did not do this as we did not pre-specify a point at
which we would deem a study to be at overall ’high risk of bias’.
Assessment of reporting bias
Quantitative methods for exploring reporting bias are not well
established for studies of diagnostic test accuracy (DTA) (Bossuyt
2013)
R E S U L T S
Results of the search
The search yielded 47,807 records, and 24,310 remained after re-
moving duplicates (Figure 2). We reviewed the full text of 317
records (referring to 270 studies) and excluded 245 (referring to
222 studies), most commonly because of ineligible study design.
We were unable to classify eight records because they were only
available as abstracts and we could not obtain sufficient informa-
tion about them despite attempting to contact authors (Gungen
2002; Jianbo 2013; Kornsey; Kvitting 2013; Orsi; Shaaban 2013;
Upadhyaya 2010; Yu 2012).We found one ongoing study that had
no results on diagnostic accuracy (Guiata 2012). We attempted to
contact the authors of 17 articles, received replies from the authors
of 10 and were able to include additional unpublished data from
one study (Carnero-Pardo 2013). We included 70 articles, refer-
ring to 48 studies, in our synthesis. Table 1 and Table 2 give details
of the studies in the community and primary care, respectively. Of
the 48 studies that we reviewed, we were able to perform meta-
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analysis on 28 community-based studies (44 articles) and 6 stud-
ies in primary care (8 articles). Of the 28 community studies that
we included in the meta-analysis, 7 reported accuracy estimates
for level of education (referred to as ’education adjusted’) and 21
reported accuracy estimates at various cut points. We could not
include the remaining 14 community studies in the meta-analy-
sis because paired 2 x 2 data was not available despite contacting
authors. However, we include them in this report for transparent
reporting, because we believe 2 x 2 data should exist based on the
study design and characteristics. Two of the six studies in primary
care were conducted in symptomatic people, selected to the study
on the basis of a reported concern about cognition(Carnero-Pardo
2013; Cruz-Orduna 2012), whereas the other four primary care
studies and all of the community studies were in asymptomatic
people, for whom reported cognitive difficulty was not a criterion
for inclusion in the study. Studies reported the target condition as
all-cause dementia syndrome, so we could not analyse diagnostic
accuracy by subtype.
In the meta-analysis there were 12,110 participants in community
studies and 1681 participants in primary care studies. For com-
munity-based studies we were able to performmeta-analysis using
the bivariate method at cut points of 24 and 25 and in studies
that adjusted accuracy estimates for level of education (referred to
as ’education adjusted’). The Summary of findings presents these
results. For studies in primary care, we could not perform meta-
analysis using the bivariate method due to heterogeneity in the cut
points reported, and so we cannot report a summary sensitivity
and specificity.We include further details of the studies, including
the design, sampling, reference standard and population, in the
Characteristics of included studies.
We found one prior systematic review on the same topic, which
included five studies that were excluded by our methods (Mitchell
2009). Table 3 presents the details of these studies. Cullen 2005
and Huppert 2005, two of the five studies that we excluded, used
AGECAT as the reference standard (Copeland 1986), and the
other three studies used CAMDEX (Roth 1986). Two of the stud-
ies used a cut point of 22 to determine normal cognition (Brayne
1989; Clarke 1991), one used a cut point of 23 (Huppert 2005),
and two used a cut point of 24 (Cullen 2005; O’Connor 1989).
Methodological quality of included studies
We used QUADAS-2 to help determine the risk of bias for each
study in order to determine the confidence that patients and clini-
cians can have in the results of each study (Appendix 4; Appendix
5). We summarise the main results below and in Figure 3 and
Figure 4.
Figure 3. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies
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Figure 4. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study
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We judgedMaki 2000 andWinblad 2010 to be at high risk of bias
in the patient selection domain because Maki 2000 excluded peo-
ple who lived alone andWinblad 2010 appeared to exclude people
who were known to have dementia.We considered three studies to
be at high risk of bias in the index test domain because it appeared
that investigators did not specify the cut point before the analysis
(Lindesay 1997; Lourenco 2006; Macedo Montano 2005). We
identified nine studies that we considered to be at high risk of bias
regarding flow and timing because we had concerns about partial
verification of the index test: Eefsting 1997 administered the ref-
erence test to a proportion of each scoring band on the MMSE;
Fillenbaum 1990 administered the reference standard to a sample
of participants; Helsinki Aging Study 1994 only administered a
reference standard to people who were diagnosed with possible
dementia on the basis of an assessment by a GP; Jacinto 2011 did
not describe the flow and timing; Kathriarachchi 2005, Lam 2008
and Macedo Montano 2005 partially verified the diagnosis with
a sample of participants, but it was not clear how they selected
the sample; Scazufca 2009 appeared to exclude people who were
unable to answer items in the MMSE and said that 81 people
were not approached but did not explain why. Finally, Maki 2000
administered the reference standard to a sample of people, but we
could not reconcile the figures that were stated in the paper.
We assessedmost studies as being applicable to the reviewquestion,
though we had concerns that the selection of participants in six
might reduce their applicability (Helsinki Aging Study 1994;
Jacinto 2011; Li 2006;Maki 2000; Rosselli 2000;Winblad 2010).
We had high concern that Li 2006 used a target condition (mild
cognitive impairment and dementia) that was not applicable to
our review question and were unable to include data on diagnostic
accuracy from this study. As studies were generally at low risk of
bias - no study had more than two of four QUADAS-2 items that
were assessed as high risk of bias - we did not exclude studies from
themeta-analysis based on the risk of bias as we did not pre-specify
a point at which we would deem a study to be at overall ’high risk
of bias’.
Findings
Table 1 and Table 2 show that the accuracy of theMMSE for diag-
nosing dementia was reported at 18 cut points (MMSE score 10,
14 to 30 inclusive) in the community and 10 cut points (MMSE
score 17 to 26 inclusive) in primary care studies. Summary of
findings presents the summary diagnostic accuracy in community
studies: sensitivity 0.85 (95% confidence interval (CI) 0.74 to
0.92), specificity 0.90 (95% CI 0.8 to 0.95) at a cut point of 24
(15 studies); sensitivity 0.87 (95% CI 0.78 to 0.93), specificity
0.82 (95% CI 0.65 to 0.92) at a cut point of 25 (10 studies); and
sensitivity 0.97 (95% CI 0.83 to 1.00), specificity 0.70 (95% CI
0.50 to 0.85) when adjusted for education (7 studies). In primary
care studies, each cut point was reported by a maximum of three
studies, and we could not provide a summary of sensitivity and
specificity.
Community studies
In community studies the accuracy of theMMSE for the diagnosis
of dementia was available for 18 cut points (10, 14 to 30 inclusive)
and also adjusted for education. At a cut point of 10, accuracy was
sensitivity 0.11 (95% CI 0.00 to 0.48), specificity 0.95 (95% CI
0.93 to 0.97) (Phantumchinda 1991), and at a cut point of 30
accuracy was sensitivity 1.00 (95% CI 0.98 to 1.00), specificity
0.00 (95% CI 0.00 to 0.01) (Kahle-Wrobleski 2007). Figure 5
presents the summary ROC curve for community studies in the
main analysis, including all 21 studies that reported 2 x 2 data,
and Figure 6 presents the linked forest plot.
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Figure 5. Summary ROC Plot of analysis 2 main community
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Figure 6. Forest plot of analysis 2 Main community
We were able to include seven community studies in the meta-
analysis of diagnostic accuracy in studies whose original investiga-
tors adjusted the MMSE for education. We present the summary
ROC in Figure 7 and the forest plot in Figure 8. The pooled es-
timate for the diagnostic accuracy was sensitivity 0.97 (95% CI
0.83 to 1.00), specificity 0.70 (95% CI 0.50 to 0.85). We were
able to include 15 studies in the meta-analysis of diagnostic ac-
curacy at a cut point of 24; Figure 9 presents the summary ROC
curve and Figure 10, the forest plot; the pooled estimate for the
diagnostic accuracy was sensitivity 0.85 (95% CI 0.74 to 0.92),
specificity 0.90 (95%CI 0.82 to 0.95).We were able to include 10
studies in the meta-analysis of diagnostic accuracy at a cut point
of 25; Figure 11 presents the summary ROC and Figure 12, the
forest plot. The pooled estimate for the diagnostic accuracy was
sensitivity 0.87 (95% CI 0.78 to 0.93), specificity 0.82 (95% CI
0.65 to 0.92).
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Figure 7. Summary ROC plot of analysis 3 community, education adjusted. The black filled dot indicates
the summary point estimate of diagnostic accuracy, the smaller dotted bubble indicates the 95% confidence
interval around the summary point (containing the ’true value’ within that region 95% of the time on the basis
of the available data) and the larger dashed bubble indicates the 95% prediction region (containing results from
a new future study 95% of the time).
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Figure 8. Forest plot of analysis 3 MMSE community, education adjusted
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Figure 9. Summary ROC plot of analysis 4 MMSE at 24 normality (23/24). The black filled dot indicates the
summary point estimate of diagnostic accuracy, the smaller dotted bubble indicates the 95% confidence
interval around the summary point (containing the ’true value’ within that region 95% of the time on the basis
of the available data) and the larger dashed bubble indicates the 95% prediction region (containing results from
a new future study 95% of the time).
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Figure 10. Forest plot of analysis 4 MMSE at 24 normality (23/24).
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Figure 11. Summary ROC plot of analysis 5 MMSE at 25 normality. The black filled dot indicates the
summary point estimate of diagnostic accuracy, the smaller dotted bubble indicates the 95% confidence
interval around the summary point (containing the ’true value’ within that region 95% of the time on the basis
of the available data) and the larger dashed bubble indicates the 95% prediction region (containing results from
a new future study 95% of the time).
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Figure 12. Forest plot of analysis 5 MMSE at 25 normality.
Primary care studies
In symptomatic people the accuracy of theMMSE for the diagno-
sis of dementia was available for 9 cut points (17 to 25 inclusive).
At a cut point of 19, accuracy was sensitivity 0.80 (95% CI 0.52
to 0.96), specificity 0.86 (95% CI 0.80 to 0.91) in Cruz-Orduna
2012 and sensitivity 0.88 (95% CI 0.79 to 0.95), specificity 0.87
(95% CI 0.82 to 0.91) in Carnero-Pardo 2013 .Carnero-Pardo
2013 reported accuracy for cut points from 17 (sensitivity 0.70
(95%CI 0.59 to 0.80), specificity 0.93 (95%CI 0.89 to 0.96)), to
25 (sensitivity 1.00 (95% CI 0.95 to 1.00), specificity 0.38 (95%
CI 0.32 to 0.44)). At the traditional cut point of 24, the accuracy
was sensitivity 1.00 (95% CI 0.95 to 1.00), specificity 0.46 (95%
CI 0.40 to 0.52).
In asymptomatic people the accuracy of the MMSE for the diag-
nosis of dementia was available for 9 cut points (18 to 26 inclu-
sive). Lourenco 2006 reported that at a cut point of 18, accuracy
was sensitivity 0.35 (95% CI 0.24 to 0.46), specificity 0.94 (95%
CI 0.90 to 0.97), and at a cut point of 26 the accuracy was sensi-
tivity 0.90 (95% CI 0.81 to 0.95), specificity 0.50 (95% CI 0.43
to 0.56). At the traditional cut point of 24, Lourenco 2006 found
a sensitivity of 0.65 (95% CI 0.59 to 0.72) and specificity of 0.65
(95% CI 0.59 to 0.72), while Pond 1994 reported sensitivity 0.95
(95%CI 0.92 to 0.97) and specificity 0.95 (95%CI 0.92 to 0.97).
Figure 13 presents the summary ROC curve for primary care stud-
ies and Figure 14, the forest plot.
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Figure 13. Summary ROC plot of analysis 1 Main analysis primary care
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Figure 14. Forest plot of analysis 1 Main analysis primary care
Heterogeneity
We used additional models to explore potential heterogeneity in
the diagnostic accuracy of the main analysis by age, sex, conduct
and reference standard. Additionally we attempted to evaluate het-
erogeneity by education andmeanMMSE score in the sample, but
this was not possible because these data were poorly reported in the
original studies. We found no evidence against the null hypothesis
of no heterogeneity for age (P = 1.00 likelihood ratio (LR) Chi
2(4) = − 9.49), sex (P = 1.00 LR Chi2(4) = − 20.68) or conduct
(P = 0.0647 LR Chi2(4) = 8.85). There was some evidence against
the null hypothesis of no heterogeneity by reference standard (P
= 0.0342 LR Chi2(8) = 16.63).
Sensitivity analyses
We did not perform any sensitivity analyses.
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Summary of findings
What is the accuracy of the M ini M ental State Examination (M M SE) for diagnosing current dementia compared to clinical
diagnosis of dementia?
Index test: M ini Mental State Examinat ion (MMSE) administered to the pat ient. We restricted inclusion to the original 30
item MMSE but did not restrict by language
Reference test: clinical diagnosis of dementia made using any recognised classif icat ion system
Studies: cross-sect ional studies but not case-control studies
Limitations: there were too few studies to perform meta-analysis at each cut point. We could not perform bivariate meta-
analysis on studies in primary care as there were too few
Population: adults resident in the community
Setting: community
Test Summary accuracy
(95% CI)
No. of participants
(studies); median (IQR)
Dementia prevalence
median (IQR)
Quality, Implications
and Comments
MMSE at cut point 24
indicat ing normal
Sensit ivity 0.85 (0.74,
0.92)
specif icity 0.90 (0.82,
0.95)
10969 (15);
435 (272 to 737)
7.4% (5.5% to 20.1%) Studies were generally
at low risk of bias (none
were at high or unclear
risk in more than 1 do-
main)
In a group of 1000 peo-
ple where 7 have de-
mentia, 105 test posi-
t ive, 6 of whom have
dementia, and 895 test
negat ive, 1 of whom
has dementia
A large number of
people would need to
be evaluated further
to ident if y the people
with dementia. 1 per-
son with dementia is
’m issed’
MMSE at cut point 25
indicat ing normal
Sensit ivity 0.87 (0.78,
0.93)
specif icity 0.82 (0.65,
0.92)
5894 (10)
316 (246 to 713)
8.4% (6.0% to 19.0%) 1 study was high risk for
pat ient select ion and
unclear risk in 2 others
(Winblad 2010). 1 other
study was high risk in
pat ient f low (Eefst ing
1997). Otherwise stud-
ies were at low risk of
bias.
In a group of 1000 peo-
ple where 8 have de-
mentia, 186 test posi-
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t ive, 7 of whom have
dementia, and 814 test
negat ive, 1 of whom
has dementia
Impact is sim ilar to use
of the 24 cut point
but more people require
further evaluat ion
MMSE at cut point ad-
justed for educat ion
Sensit ivity 0.97 (0.83,
1.00)
specif icity 0.70 (0.50,
0.85)
8442 (7)
294 (120 to 947)
13.8% (2.4% to 27.4%) 2 studies were at high
risk of bias for pat ient
f low (Jacinto 2011;
Lam 2008), otherwise
studies were at low or
unclear risk of bias.
In a group of 1000 peo-
ple where 14 have de-
mentia, 309 test posi-
t ive, 14 of whom have
dementia, 691 test neg-
at ive, none of whom
have dementia
Many people need to
be further evaluated to
ident if y the people who
have dementia but ev-
erybody with dementia
is ident if ied
CI: conf idence interval; IQR: interquart ile range.
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D I S C U S S I O N
Summary of main results
In community studies of asymptomatic people, with a cut point of
24 indicating normal cognition, theMMSEhad pooled diagnostic
accuracy of sensitivity 0.85 (95%CI 0.74 to 0.92), specificity 0.90
(95% CI 0.82 to 0.95). The pooled diagnostic accuracy at a cut
point of 25 was similar, whereas theMMSE adjusted for education
was better for screening, at the cost of more false positives, with
sensitivity 0.97 (95% CI 0.83 to 1.00) and specificity 0.70 (95%
CI 0.50 to 0.85). In primary care, a single study of symptomatic
people reported that a cut point of 17 had higher specificity (0.93
95% CI 0.89 to 0.96) than a cut point of 24 (0.46 95% CI 0.40,
0.52), with some additional false negatives as the sensitivity fell
from 1.00 (95% CI 0.95 to 1.00) to 0.70 (95% CI 0.59 to 0.80)
(Carnero-Pardo 2013).
The risk of bias in the included studies is summarised in Figure 3.
We generally had low concern about bias in the included studies.
There were some differences between studies, but we found no
evidence against the null hypothesis of no statistical heterogeneity
by age, sex, or conduct of the index test. We found some evidence
of heterogeneity by reference standard, but most of the studies
used the clinical DSM definition for the target condition of all-
cause dementia. Some of the confidence intervals around the point
estimates are wide, which indicates some uncertainty in our results
because of the limitations of the underlying data.
Strengths and weaknesses of the review
Weused a comprehensive and sensitive search strategy that yielded
substantially more results than a similar, earlier review that found
only 775 articles and included a total of 21 studies in any setting
(Mitchell 2009).We followed our pre-specified peer-reviewed pro-
tocol, which did not specify CAMDEX, CERAD or AGECAT as
appropriate reference standards. Consequently we excluded stud-
ies that used these reference standards.We found few studies in pri-
mary care that used the references standards we specified and even
fewer in participants selected on the basis of symptoms (symp-
tomatic primary care). We found sufficient studies to perform
meta-analysis of test accuracy and to explore heterogeneity, but
our evaluation was limited by poorly reported factors (education
and mean MMSE score). On the other hand, assessing hetero-
geneity by factors that are not measured at the study level (e.g.
education, severity of diagnosis or subtype diagnosis) is generally
not recommended (Bossuyt 2013).We did not use a separate form
(as we stated in the protocol), but we extracted data directly into
RevMan after we set up the file using a set of pilot studies, as
we pre-specified (RevMan 2014). This was because we were con-
cerned about introducing errors when copying data from an Ac-
cess database into RevMan given the large number of studies. At
least two authors, and usually three, performed data extraction and
quality assessment, checking the accuracy of the extracted data in
real time.
Applicability of findings to the review question
We consider that our findings are likely to be applicable to our
review question.We had aimed to evaluate the strength of evidence
for the accuracy of the MMSE for diagnosing Alzheimer’s disease
dementia and other dementias, but studies only reported all-cause
dementia, so we were not able to evaluate the diagnostic accuracy
by subtype. Despite this, for clinicians and patients in primary
care and community settings, themost important clinical question
determining intervention and follow-up is often, ’Does this person
have a dementia now?’, and our review addresses this.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In this section we present results using natural frequencies, but
these do not take account of the confidence intervals and uncer-
tainty in our results and so should be interpreted with caution.
If clinicians would like to use theMMSE in primary care to rule in
a diagnosis of dementia in a symptomatic person, there is evidence
from one study that a cut point of 17 to indicate normal cognition
would have higher specificity than a traditional cut point of 24,
with a slightly lower sensitivity: the median prevalence of demen-
tia in primary care studies was 18.5%, so - rounding up to 20% for
the sake of convenience - of 1000 people in this setting, with 200
expected to have dementia at a cut point of 17 indicating normal,
clinicians could expect 196 to test positive, of whom 140 (71%)
would truly have dementia; 804 would test negative, of whom 744
(93%) would not have dementia (Carnero-Pardo 2013). If the test
were being used to identify anybody who might have dementia
regardless of concern about cognition, then there is evidence from
seven community-based studies that the accuracy of the MMSE
adjusted for education has a higher sensitivity than when a cut
point of 24 or 25 is used (based on the meta-analytical estimates
of 15 studies and 10 studies, respectively), although the specificity
is lower and consequently there are more false positives, and this
mightmean unnecessary further evaluation for some people. Clin-
icians and patients can be confident that the MMSE is likely to be
of some diagnostic value at cut points of 24, 25 and adjusted for
education, though the uncertainty in the estimates does not allow
us to confidently choose between these three approaches.
We consider that the evidence we present supports the use of the
MMSE as part of a diagnostic evaluation for dementia, but it
should not be used in isolation to confirm or exclude disease. Our
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review allowed for a diagnosis of dementia at any stage of disease;
we did not explore heterogeneity by disease spectrum, and to do
so would have been challenging and not recommended (Bossuyt
2013).However, wewould advocate considering carefully howour
results apply in the clinical context. When considering the studies
that reported the highest cut point in asymptomatic people in the
community and the lowest cut point in symptomatic people in
primary care, then based on Burkart 2000 at a cut point of 29
indicating normal cognition in a sample of 1000 asymptomatic
people in the community where 65 have dementia, we would
expect that 367 people would have a normal result, of whom 2
would have dementia. Conversely, based on Carnero-Pardo 2013,
at a cut point of 17 indicatingnormal cognition in a sample of 1000
people in primary care, where 200 have dementia, wewould expect
that 196 test positive, of whom 56 would not have dementia.
Thus, a diagnosis of dementia may still be possible even with high
(normal) scores on MMSE, and people may not have dementia
even with low (abnormal) MMSE scores. The use of the MMSE
in the community will usually be followed up by further clinical
evaluation of people who have abnormal scores.
Implications for research
The MMSE is now protected by copyright and is likely to be used
less in clinical practice in the future than it has been in the past, but
these data may be useful for research studies. We were surprised to
find so few studies in symptomatic people. Original study authors
did not optimally report factors that might affect performance of
the test.
Many of the studies that we included, particularly those in the
community, are screening studies (see Clinical pathway). An age-
ing population is prompting policymakers to consider changes
to the traditional clinical pathway, and in the future non-special-
ist clinicians in primary care may be responsible for diagnosing
straightforward cases of dementia (Barrett 2014). However, we
found very few studies to inform policymaking in this area.
We recommend that future work evaluate the diagnostic accuracy
of tests in the context of the diagnostic pathway experienced by
the patient: that is, allowing for the presence or absence of sub-
jective memory problems, symptoms and the view of caregivers
and clinicians. We also suggest that in addition to testing accu-
racy alone,investigators report how undergoing the MMSE (or
other similar cognitive test) changes outcomes that are relevant
to patients and clinicians, such as time to diagnosis, initiation of
treatment or care package, subsequent additional testing and place
of care. We advocate the use of STARDEM reporting criteria to
aid transparent reporting of future diagnostic test accuracy studies
with dementia as the target condition (Noel-Storr 2014).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
ADAMS Study 2007
Study characteristics
Patient sampling The ADAMS study sample came from the nationally representative Health and Retirement Study
(HRS) as sample frame. From the larger HRS sample, a random subsample of 1770 individuals
aged 70 or over was selected for participation in the ADAMS, with the goal of obtaining clinical
assessments on about 850 individuals. In order to ensure a sufficient number of respondents across
the full range of cognitive ability, investigators stratified the sample based on cognitive status. 5
cognitive strata (ranging from ’low functioning’ to ’high normal’) were defined based on respondents’
performance on the cognitive measures in the most recent HRS interview (either 2000 or 2002,
depending on the timing of recruitment into the ADAMS). Investigators used scores on the full
set of HRS cognitive tests (ranging from 0 to 35 points) to classify self-respondents, and scores on
the IQCODE were used to classify proxy respondents. The cognitively normal group was further
stratified by age (70-79 versus ≥ 80) and sex in order to ensure adequate numbers in each of these
subgroups
The original HRS sample consisted of individuals born between 1931 and 1941, inclusive. This
sample came from a screening of 69,336 households that was conducted in 1992. That sample of
households was generated using a multi-stage, clustered area probability frame. The second sample
was generated for what began as a separate study: Asset and Health Dynamics among the Oldest
Old (AHEAD). This sample consists of individuals born in 1923 or before. Those born between
1914 and 1923, and about half of those born in 1913 or before, were identified through the same
household screening used to identify the original HRS sample. The other half of those born in
1913 or before were identified using the Medicare enrolment files maintained by the Health Care
Financing Administration (HCFA, since renamed the Centres for Medicare & Medicaid Services,
or CMS). In 1998, the HRS and AHEAD studies were merged, with a single interview schedule
856 adults were sampled from ADAMS, however 155 of these were excluded due to not completing
the MMSE
Patient characteristics and set-
ting
Participants included 509 white, 124 African Americans, and 68 Latinos (> 70 years old) from the
Aging, Demographics, and Memory Study who completed the MMSE and FOME. There were
314 men, average age 80.5 years. Average education was 9.2 years. Average MMSE score was 23
Index tests MMSE, non-validated Spanish versions where necessary.
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV.
Participants consented to a 3-4 h structured assessment conducted in-home, including a medical
examination with a nurse and a neuropsychological battery with a trained psychometrician
A panel of 3 expert scientists, including a neurologist, cognitive neuroscientist, and geropsychiatrist
determined the participants’ initial DSM-IV cognitive status based on the in-home diagnostic
evaluation, which assessed several cognitive domains
The final cognitive status was made by a consensus panel of experts based on a review of the infor-
mation collected through the neuropsychological, medical, and neurological assessment measures
We assess this as meaning that not all 701 participants were clinically evaluated by a specialist
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ADAMS Study 2007 (Continued)
Flow and timing All participants who received MMSE also received the reference standard. Note that this was due
to the way that the sample was selected and we have accounted for this in the QUADAS-2 item
regarding inappropriate exclusions
Comparative
Notes Participants were excluded if they couldn’t/hadn’t completed the MMSE
We contacted the authors to ask them to provide 2 x 2 data, unstratified by ethnicity, but they were
unable to do this. The diagnostic accuracy stratified by ethnicity was:
For white participants, normal vs. dementia: sensitivity 0.87, specificity 0.98 (no confidence inter-
vals; cut point 24 indicating normal; 509 participants, 129 with dementia)
For African American participants, normal vs. dementia: sensitivity 0.92, specificity 0.84 (no con-
fidence intervals; cut point 21 indicating normal; 124 participants, 37 with dementia)
For Latino participants, normal vs. dementia: sensitivity 0.92, specificity 0.84 (no confidence in-
tervals, cut point 21 indicating normal; 68 participants 13 with dementia)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Low
DOMAIN 3: Reference Standard
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ADAMS Study 2007 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Aevarsson 2000
Study characteristics
Patient sampling Community sample of adults on census
Patient characteristics and set-
ting
All 85-year olds, in Goteborg, Sweden, who were registered for census, were invited for survey and a
systematic subsample (N = 494) were clinically evaluated and comprise this diagnostic test accuracy
study. 1986, 1987
Index tests Swedish MMSE
Target condition and reference
standard(s)
Dementia. DSM-III-R criteria and subtypes - possibility of incorporation bias as MMSE formed a
part of the reference standard
Flow and timing Information collected at 1 interview, but informant interview considered separately to examination
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Aevarsson 2000 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
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AMSTEL Study 1997
Study characteristics
Patient sampling Subjects were participants in AMSTEL 2 phase population study. 4051 participants aged 65-84
were recruited. The population base for the AMSTEL study included all individuals aged 65-84
who lived in Amsterdam and were registered with a GP. Within each practice a fixed proportion of
respondents was randomly selected from each of four 5-year age strata (65-69, . . . 80-84)
Patient characteristics and set-
ting
64.2% women, average age 75.4, 8.2 years of education, mean MMSE score 26.9
Index tests Non-validated Dutch translation of MMSE
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R using CAMDEX as a framework
Flow and timing 4051 participants had MMSE, in phase II everybody with an MMSE of < 22, an age stratified
sample of people with MMSE scores > 22 were invited (N = 511). Those people were seen and
assessed a median of 7 weeks (range 1-22) after the index test
Comparative
Notes We were unable to include this in the meta-analysis. The marginal totals were 261 disease positives,
3790 disease negatives, 72 test positives. After several lots of correspondence with the authors, we
were provided with some sensitivity and specificity data (for cut point 24 indicating normality this
was sensitivity 0.69, specificity 0.47); however, it was not possible to reconcile the 2 sets of figures
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
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AMSTEL Study 1997 (Continued)
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Baker 1993
Study characteristics
Patient sampling The sample was drawn from 2 sites in San Antonio, Texas: a senior citizen housing complex and a
senior centre. The senior housing complex was comprised of 72 apartments in 2-storey dwellings
located in a section of the city that was predominantly African American. The senior citizen centre
was located in the same area. In addition to providing hot meals, health screening programmes, and
various community activities, it also provided the opportunity for volunteer activities
Patient characteristics and set-
ting
The sample was African American and comprised 41 females and 14 men (75% female), mean age
was 79. Mean MMSE 26
Index tests MMSE
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Baker 1993 (Continued)
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing Reference standard was applied to all 55 participants within an average of 7 days (3 interviews were
completed outside of this time-frame due to conflicting schedules)
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
Yes
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study?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Brodaty 2002
Study characteristics
Patient sampling ”Of 380 community-dwelling patients recruited by their GPs, 283 completed the study. Patients
were included if they were aged 75 years or more regardless of cognitive status. To imitate usual
practice, subjects aged 50 to 74 suspected of having a memory problem were also included. Patients
were excluded if they resided in a nursing home; if they had a diagnosis of depression or delirium;
or if poor English language abilities, sight, or hearing precluded testing
“GPswere asked to administer theGPCOG(before subsequent refinement) andAMTto consecutive
eligible patients and to contact an informant (by telephone or in person) who had known the patient
for at least 5 years. Approximately 5 weeks later, a research psychologist visited the patient at home,
administered the various instruments, including the CAMDEX and the GPCOG again, and, where
possible, interviewed an informant.”
Patient characteristics and set-
ting
“There were no differences between participants diagnosed with dementia and those without de-
mentia as regards gender (40.6% of the sample were male), relationship with informant (40.6%
were spouses), living arrangements (87.6% lived in a private home and the others in retirement
villages or hostels), or education (mean 9.4 years). Patients’ overall mean age was 79.6 years (range
56-94); 32 patients (11.3%) were aged 50 to 75. Those diagnosed with dementia were older (mean
80.7 years) than those without dementia (79.1 years) and less likely to be living with an informant
(71.1% and 82.9%, respectively).”
Index tests “Psychologist-administered MMSE”
Target condition and reference
standard(s)
Dementia as diagnosed according to DSM-IV
Flow and timing “[D]iagnoses of dementia and delirium were established according to DSM-IV criteria on all 156
subjects suspected to be cognitively impaired (CAMCOG score < 85) and a random sample of 20
cognitively intact individuals (CAMCOG score > 84) (62.2% of all cases reviewed). No case was
found to meet criteria for delirium.”
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Brodaty 2002 (Continued)
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
No
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Burkart 2000
Study characteristics
Patient sampling Age-stratified random sample of 1305 subjects with over-sampling of advanced age, invited by letters
and telephone
Patient characteristics and set-
ting
Community: 291 consented but only 256 completed tests n = 256 for analysis
Index tests MMSE (as part of SIDAM = Structured Interview for the Diagnosis of Dementia of the Alzheimer
Type, Multi-infarct dementia and dementias of other aetiologies). SIDAM takes 28 minutes rather
than MMSE 7 minutes (Zaudig 1991)
Given by trained medical students
Target condition and reference
standard(s)
Dementia. ICD-10 and DSM-III-R
Flow and timing Medical students performed personal interviews. Psychiatrists made formal diagnoses
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Burkart 2000 (Continued)
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Unclear
Callahan 2002
Study characteristics
Patient sampling “For the community-based sample, the geographic target area consisted of 29 contiguous census
tracts with a total population of 82,387 and total households of 32,954 in the 1990USCensus. Black
persons comprised 86% of this population, which also represents more than 2/3 of Indianapolis’
elderly black population. A random sample of 60% of residential addresses was constructed by the
IndianapolisWater Company using all residential addresses in the target area, and identified homes
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were then visited by interviewers from May 1, 1992-April 30, 1993. Patients residing in nursing
homes are not included in this sample. Eligible subjects had to be (1) a resident at a sampled address,
(2) black, and (3) age 65 years or older. A total of 7590 households were approached, 4915 of which
did not have an eligible resident. Of the 2582 eligible persons, 2212 (85.7%) agreed to participate.
These subjects were screened with the Community Screening Instrument for Dementia (CSI-D) . .
”Items for the CSI-D were selected from several widely used screening instruments including . . .
the Mini-Mental State Examination.“
Patient characteristics and set-
ting
Community-based sample only
344 participants
Mean age 74.4 years (range 65-99)
59.4% women
100% black
10.4 years of education
4.3% dementia
26.4% cognitively impaired
Mean MMSE 26.1
Index tests MMSE
Target condition and reference
standard(s)
Dementia, DSM-III-R AND ICD-10 (Both necessary).
NINCDS/ADRDA for possible or probable Alzheimer’s disease
Flow and timing ”A stratified sample of the community-based subjects was selected for full clinical assessments based
on their performance on the CSI-D. All subjects who scored poorly on the CSI-D were invited for
clinical assessments and we also selected a 50% sample of those with intermediate performance, and
a 5% sample of those with good performance. Patients aged 75 and older were over-sampled in the
5% sample so that 75% of the patients with good performance on the CSI-D would be 75 years of
age or older . .
“There were 351 patients selected for full clinical assessments but seven were too severely impaired to
complete the standardized questionnaires. Data for the remaining 344 (98%) subjects are included
here”
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Callahan 2002 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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Carnero-Pardo 2013
Study characteristics
Patient sampling Sampled fromGranada andMadrid, Spain. Sampling was prospective and consecutive and included
all those subjects who had memory loss complaints from the patient, the family or the person
accompanying them, or that was suspected by the doctor on the basis of general observations
Patient characteristics and set-
ting
255 (70.8%) women and 105 men, average age 72.6 years, 30 people (8.3%) were illiterate, 180
had less than primary education, 180 had more than primary education. Average MMSE score was
21.1
Index tests MMSE The MMSE was carried out in primary care, validated in the NORMACODEM study
(Blesa 2001) “doing without the spelling of world backwards” - this is one of the items in the
MMSE, and an alternative question of serial subtractions of 7 from 100 may be used instead
Target condition and reference
standard(s)
Dementia, DSM-IV-TR
The reference standard was conducted in specialised care by an expert neurologist, without knowing
the results of the MMSE
Flow and timing All of the selected subjects independent of the results of the screening test underwent the reference
standard (complete verification)
In the study fromGranada, as it is explained in the primary study record, themaximum time interval
between assessments in the Primary Care Center and Cognitive Behavioral Neurology Unit was
2 weeks. In the study from Madrid, the interval between both evaluations was 31.05 ± 49.2 days
(range 0-329)
The study in Granada was conducted in 4 health centres during 1 year (1 Feb 2008 to 31 Jan 2009)
; whereas the sample from Madrid was largely (174 subjects) from 1 health centre and was selected
between 1 April 2000 and 31 October 2002
Comparative
Notes Translated by Mr William Eustace on 31 October 2014.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
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Carnero-Pardo 2013 (Continued)
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Correira 2001
Study characteristics
Patient sampling City of Recife, Brazil. The elderly were identified and invited to participate in a survey by a trained
census or community health agent working in the area who scheduled an interview with the re-
searcher
Patient characteristics and set-
ting
Community-dwelling elderly aged 65 or more, had to have an informant who had known them for
at least 10 years prior to the study
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Correira 2001 (Continued)
Index tests MMSE conducted in Portuguese. The MMSE cut point scores for cognitive impairment according
to education were set as follows: Illiterate = 20, 1-4 years of education = 25, 5-8 years of education
= 26, 9-11 years of education = 28, and 29 for those with more than 11 years of schooling
Target condition and reference
standard(s)
Dementia. DSM-IV
Flow and timing The data were collected from October 2008 to January 2009
Comparative
Notes The education adjusted thresholds, particularly for those with more than 11 years of schooling were
very high (29 out of 30 for this group,) and we are unsure how this would be applicable
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Correira 2001 (Continued)
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Cruz-Orduna 2012
Study characteristics
Patient sampling Systematically included all individuals who attended the 7 medical clinics of the Pena Prieta Primary
Care Centre (Health District 1, Autonomous Community of Madrid) between 1 April 2000 and
31 October
2002.
Patient characteristics and set-
ting
Age 50-88 inclusive
Any complaint or suspicion, raised by the patient, an informant or the PCP, related to cognition,
cognition-
related functions (i.e. performance of activities of daily living, ADLs) or behaviour, of unknown
aetiology
Those with no informant were excluded
70.9% women
In half of the cases (49.5%), patient and informant lived together
Index tests MMSE (validated Spanish version)
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV-R
Flow and timing If the patient and the informant gave their consent, the detection instruments were applied and an
appointment
was made to carry out a formal neuropsychological workup some days later. Patients who did not
present with an informant and wished to undergo the formal neuropsychological evaluation and
assessment by a neurologist were permitted to do so, although they were not included in the present
study
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Comparative
Notes 27% of the 15 people with dementia were illiterate, compared with 7% of the people with MCI
and 0 of those with normal cognition. 9% of those with normal cognition had a superior education
compared with 4% of those with MCI and 0 of those with dementia
The mean MMSE score we quote in the covariate section is taken from the related Olazarán paper
which includes those people with no informant (16 people who weren’t included in the analysis):
25.1 = NCI
20.8 = MCI
16.1 = dementia
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
Yes
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be repeated in an independent
study?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Eefsting 1997
Study characteristics
Patient sampling Multi-stage stratified randomised sampling
Patient characteristics and set-
ting
Community based population
Index tests MMSE Dutch validated version
Target condition and reference
standard(s)
Dementia
Flow and timing A proportion of each scoring band was given the reference standard within 6 weeks of index test
Comparative
Notes The diagnostic utility was weighted to the whole population (2151) based on 390 people who were
clinically assessed
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
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Study characteristics
Patient sampling Random sample of 402 people were invited, of whom 358 participated
Patient characteristics and set-
ting
Over 85 in Munich in 1990. Sample included residents of homes for the elderly
Index tests MMSE included in SIDAM
Target condition and reference
standard(s)
All dementias according to DSM-III-R
Flow and timing Index test and reference standard were done concurrently
Comparative
Notes There may be some incorporation bias due to same person doing both tests concurrently
No information on diagnostic accuracy is available despite attempting to contact the authors
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Fillenbaum 1990
Study characteristics
Patient sampling Stratified from larger sample of 4164 residents. They sampled based on the SPMSQ score and
assessed 164 people with MMSE, all of whom underwent a reference standard
Patient characteristics and set-
ting
Half of the sample lives in a primarily urban county, half in rural counties. All levels of education
and socioeconomic status represented. Mixed ethnicity. 54% black. > 65 years old
Index tests MMSE administered as part of a battery of tests
Target condition and reference
standard(s)
Dementia according to DSM-III
Flow and timing We have concerns because although 164 people underwent both index test and reference standard,
the diagnostic utility is presented as representative of 4164 even though the vast majority of them
didn’t undergo either of the tests
Comparative
Notes The diagnostic utility was weighted to the whole population (4164) based on 164 people who
were clinically assessed. There was no raw data for the 164 people who actually received the test.
Specificity was presented for black people and white people respectively as 58% and 94% and
sensitivity was reported as 100% in both groups, though as stated we have concerns because the
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figures are “weighted to represent the total five county black and white community”. No raw data
is available despite attempting to contact authors
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
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Fillenbaum 1990 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Frank 1996
Study characteristics
Patient sampling 1692 community-dwelling people aged 55 and older from the Rancho Bernardo study
Patient characteristics and set-
ting
Of the sample, 380 people were in this analysis aged 65-94. 75% of men and 64% women attended
college. There were 167 men and 213 women
Index tests MMSE
Target condition and reference
standard(s)
Alzheimer’s disease diagnosed according to NINCS-ARDRA
Flow and timing No information given on timing. It would appear that everyone who underwent the index test also
received the reference standard
Comparative
Notes No information on diagnostic accuracy was available despite attempting to contact the authors
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
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Frank 1996 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
Yes
Helsinki Aging Study 1994
Study characteristics
Patient sampling A random sample was identified from the community register which included all citizens ofHelsinki:
300 75-year olds, 300 80-year olds and 300 85-year olds living in Helsinki on 1 January 1989 - a
total 656 participants, which was 83% of the sample (240 aged 75, 214 aged 80 and 202 aged 85)
Patient characteristics and set-
ting
Community sample of people > 75 in Helsinki, Finland. Urban population. Reference standard was
given only to those with a CDR score of ≥ 0.5 (i.e. those with MCI or dementia)
Index tests MMSE (presumably Finnish or Russian but not stated)
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Helsinki Aging Study 1994 (Continued)
Target condition and reference
standard(s)
All dementia as diagnosed by DMS-III-R
Flow and timing 17 subjects were unable to complete the MMSE due to severe dementia that was diagnosed at
reference standard. Subjects were given a CDR as assessed by a GP. On the basis of this, screen
positives (people scoring 0.5 or more) were given neurological evaluation (N = 174)
Comparative
Notes Because of partial verification it is not possible to fully complete the 2 x 2 table as only information
on people who had dementia is available
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Heun 1998
Study characteristics
Patient sampling Subjects were a stratified sample with an over-representation of older andmale subjects for invitation.
Interview rate was 291 of 1193. Participants were younger, more often male and cognitively normal
than invited population
Patient characteristics and set-
ting
Community setting. Patients aged between 60-100
Index tests MMSE as part of SIDAM
Target condition and reference
standard(s)
Dementia according to DSM-III-R
Flow and timing MMSE was conducted as part of the SIDAM and formal diagnosis was made with the information
gathered concurrently at a later point
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Heun 1998 (Continued)
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
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Iavarone 2006
Study characteristics
Patient sampling A random sample of 300 residents out of 1089 residents > 60 years of age living in San Marcinello
(Campania) received door-to-door visit by a specialised team including a geriatrician and a 5th year
psychology student
Patient characteristics and set-
ting
Residents of a rural community in Southern Italy (San Marcinello, province of Caserta). Average
age was 71.9, average 3.2 years of education, average MMSE was 19.7, 58% women
Index tests Validated version of the Italian MMSE, corrected for education and age
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV. Due to the fact that the reference standard was per-
formed at the same time as the index tests, we have some concerns that the outcome of the reference
standard may have been affected by the index test scores
Flow and timing Index test and reference standard information was collected in the same interview for all participants.
Due to this process there may be some risk of incorporation bias
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
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Iavarone 2006 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Jacinto 2011
Study characteristics
Patient sampling This study was carried out at the Albert Einstein long-term care institutions (LTCI), a Brazilian
facility for elderly that includes a nursing home service, an assisted living facility, and an outpatient
geriatric clinic
It was a cross-sectional study with 86 elders being invited to participate; they were independent and
semi-dependent residents living in the LTCI. 58 agreed to participate in the study; the remaining
28 who refused had no statistical difference in relation to gender, age and dependency level (P > 0.
05 - actual p value not given) when compared to the included ones
Patient characteristics and set-
ting
As population ages, LTCIs play a crucial role in the elderly care. Although LTCIs are historically
characterised as places where care-demanding people live, more frequently healthy elderly have
decided to live in these facilities for many different reasons (more intense social contact or even
enjoying what is offered at LTCIs such as balanced and proper food, recreational and physical activity
and specialised medical care). The participants had 60 or more years and mean educational level of
10 years
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Jacinto 2011 (Continued)
Index tests MMSE (we assume a validated version of the Portuguese translation). “The Mini Mental State
Examination (MMSE) has been widely studied in different populations, including in Brazil. Its
performance is closely related to schooling and cutoff scores for the Brazilian population have been
well established.”
TheMMSE cut points were adjusted according to level of education (as from Bertolucci et al 1994)
: 13 for illiterate, 18 for elementary and middle school educated and 26 for high school education
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV
Flow and timing There is no description of the flow and timing of this paper
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Unclear
DOMAIN 3: Reference Standard
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Jacinto 2011 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
Unclear
Jeong 2004
Study characteristics
Patient sampling Participants > 65 were recruited in Noam-dong, Namwon City, South Korea. Of 522 eligible, 235
completed tests
Patient characteristics and set-
ting
General community population, small South Korean city of 6883 population
Index tests Korean version of MMSE
Target condition and reference
standard(s)
DSM-IV
Flow and timing No information given on timing of reference standard. All participants received the reference stan-
dard
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Jeong 2004 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
Yes
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Kahle-Wrobleski 2007
Study characteristics
Patient sampling At the beginning of 2001, 1150 of the original Southern California Leisure World 90 + study cohort
were invited to join. N = 524
Patient characteristics and set-
ting
90+ LeisureWorld (retirement community) inhabitants
Index tests MMSE as part of 3MS
Target condition and reference
standard(s)
Dementia according to DSM-IV
Flow and timing Concurrent index test and reference standard. 86 participants failed to complete evaluation andwere
documented. 3 additional participants did not report their educational status and were excluded
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
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Kahle-Wrobleski 2007 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Kathriarachchi 2005
Study characteristics
Patient sampling All households with individuals > 65 were selected from a database of households maintained by
Colombo District University of Sri Jayewardenepura and from that, a stratified computer-generated
random sample of 400 people was selected as the study population. Of those, they evaluated only
363
Patient characteristics and set-
ting
Semi-urban community in Sri Lanka
Index tests MMSE Sinhalese version, previously validated by Da Silva 2002
Target condition and reference
standard(s)
Dementia diagnosed according to CDR
Flow and timing 400 participants were initially identified; 363 were evaluated at phase I. The rest were difficult to
assess due to unavailability of the selected individuals or their caregivers after repeated attempts
to contact them. Of the 363, a sample of 40 individuals was selected for phase II. This was a
concentrated sample of individuals who had scores ranging from normal to severe dementia on the
rating scales (MMSE, IQCODE). Of the 40 who were selected for phase II, only 37 were evaluated.
3 were not evaluated due to death or moving. Of the 37 evaluated on phase II, 14 had dementia
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Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Keskinoglu 2009
Study characteristics
Patient sampling Population of the elderly were 4012 subjects living in Narl dere, and cluster sampling method
was used for sample size. Using the Epi-Info 2000 package, the minimum sample size based on
sensitivity of 95%, 2% precision confidence interval (CI) of 95% was calculated as 407 elderly
subjects. Given the design effect (1.2), the calculated sample size was 488 elderly. The number of
houses including this sample size was requested from Turkish Statistical Institute (TUIK). TUIK
reported 2601 houses, including 50 clusters of houses for sample size of district, and 517 elderly
persons were determined to reside in a total of 2401 visited houses. Participation rate was 94.8%
(490 elderly)
Patient characteristics and set-
ting
This cross-sectional study was conducted among elderly individuals aged ≥ 65 in the town of
Narlýdere (an urban area) in the Turkish province of Izmir.Mean age of the total 490 elderly subjects
was 71.8 years (range 65-114 years; SD 6.5). Of the elderly population, 59.2% were females, 70.
8% fell in the younger age group (65-74 years) and 62.7% were married. The mean schooling year
was 1.6 years (SD 0.07), 34.7% were illiterate and 50.4% did not graduate from primary school.
In our study population, 9.8% of the subjects were socially uninsured, and 27.2% did not have any
personal income
Index tests rMMSE-T. Researchers exposed some problems regarding some items of the previously validated
Turkish version of MMSE (MMSE-T). The index test in this study is an attempt to make a Turkish
version that is more like the original Folstein MMSE
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV-R
Flow and timing All subjects who screened positive and negative were transported toDokuz Eylul UniversityHospital,
Department of Neurology in same week, and clinical diagnosis of dementia were made by the senior
neurologist using DSM-IV-R
Comparative
Notes Data on diagnostic accuracy were only available stratified by educational level, and not adjusted for
education. We attempted to contact the authors to obtain non-stratified data but had no reply
Because it is not clear what level of education would meet the definition of ’educated’ we were
unable to combine the stratified tables
Total 490 participants (170 illiterate, 77 literate, 128 primary school, 29 middle school, 53 high
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school, 3 university)
For educated elderly (definition and numbers unclear, no confidence intervals)
Cut points
19 indicating normal sensitivity 45.5%, specificity 97.8%
20 indicating normal sensitivity 63.6%, specificity 97.8%
21 indicating normal sensitivity 72.7%, specificity 97.0%
22 indicating normal sensitivity 81.8%, specificity 97.0%
23 indicating normal sensitivity 90.9%, specificity 97.0%
24 indicating normal sensitivity 90.9%, specificity 89.7%
25 indicating normal sensitivity 90.9%, specificity 78.4%
For educated elderly (definition unclear and numbers unclear, no confidence intervals)
Cut points
18 indicating normal sensitivity 76.9%, specificity 92.8%
19 indicating normal sensitivity 82.7%, specificity 92.3%
20 indicating normal sensitivity 86.5%, specificity 85.1%
21 indicating normal sensitivity 88.5%, specificity 77.9%
22 indicating normal sensitivity 92.3%, specificity 73.3%
23 indicating normal sensitivity 92.3%, specificity 65.6%
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 3: Reference Standard
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Kungsholmen Study 1992
Study characteristics
Patient sampling All inhabitants > 74 years of age in an area of Stockholm (Kungsholmen) in October 1987 (2368
individuals) living at home or in institutions. 1810 participated
Patient characteristics and set-
ting
Community setting over 74 in an area of Stockholm, Sweden. Relatively well-educated (mean 8.77
years of education)
Index tests MMSE Swedish version
Target condition and reference
standard(s)
All dementia diagnosed according to DSM-III-R
Flow and timing The nurses saw the patients to do MMSE an average of 2 months before the clinical diagnosis. In
phase 1 the MMSE was used as a screening test with 24 or above indicating normality. In phase
2 all of those scoring 23 or less (385) plus a gender- and age-matched sample (354) of the screen
negatives (total 1425) were given a clinical diagnosis
Comparative
Notes -
Methodological quality
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
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Lam 2008
Study characteristics
Patient sampling Households were randomly selected from census records in Hong Kong. 6891 > 60 were identified
and 6100 received MMSE. Nested case-control
Patient characteristics and set-
ting
Community-based sample of people aged > 60 in Hong Kong
Index tests Validated version of Chinese MMSE
Target condition and reference
standard(s)
Dementia according to DSM-IV
Flow and timing 6891 invited, 6100 participatedMMSE of those 2073 screened positive (CMMSE < 19 for illiterate
participants; < 21, 1-2 years education; < 23, 2 + years education). Of those, 1336 refused to
participate in reference standard and 737 went on to reference standard, of those 143 had dementia
194 of the 4027 who screened negative were clinically assessed, of whom none had dementia
Not clear what the timing of the reference standard was in relation to index test
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
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Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Lavery 2007
Study characteristics
Patient sampling “The Steel Valley Seniors Survey was a clinical epidemiologic study of dementia in primary care
patients aged 65 years and older in a small-town community in southwestern Pennsylvania. From
1999 to 2001, participants were recruited from the offices of 15 physicians who provided care to
older adults and agreed to provide access to patients and to medical records of consenting patients.
Participants were designated as ’symptomatic’ if self-reportedmemory complaints were documented
in their charts. Reports by family members, if any, were excluded because many participants were
unaccompanied by relatives when they visited their physicians.”
Patient characteristics and set-
ting
“Among the 642 participants selected for comprehensive assessment, those who did and did not
undergo the assessment were similar (P > 0.05 - actual p value not given) with regard to age (77.5
vs 77.7 years), sex, (68.7% vs 64.0% women), education (66.8% vs 63.3% with ≥ 12 years), and
race (92.5% vs 93.5% white). However, those assessed had a marginally higher mean (SD) MMSE
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score than those who were not (24.5 (SD 3.4) vs 24.0 (SD 3.2), P = 0.047).”
Index tests MMSE
Target condition and reference
standard(s)
Dementia according to CDR (“A standard algorithm is used to generate a summary score ranging
from 0 (no dementia) through 0.5, 1, 2, and 3, reflecting questionable, mild, moderate, and severe
dementia. A CDR rating ≥1 was treated as a diagnosis of dementia.”
Flow and timing “All participants who scored ≤ 24 on the MMSE, and a randomly selected comparison group of
participants who scored ≥ 25, were offered a comprehensive assessment at home. Of 1107 primary
care patients aged 65 + years screened with the MMSE in the physicians’ offices, the comprehensive
assessment was offered to 642 participants: 343 with MMSE scores ≤ 24 and a comparison group
of 299 randomly selected from those with scores ≥ 25. 3 of the 642 (0.5%) moved away, 3 (0.5%)
died before the home visit, and 358 (55.8%) underwent the comprehensive assessments.”
Comparative
Notes No information on diagnostic accuracy is available for the total sample, despite attempting to contact
the authors. We have used data on the people without memory complaints
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Lee 2002
Study characteristics
Patient sampling The study was conducted from June 1999 to April 2000 in Kwanak district, Seoul, South Korea.
A disproportionate age-stratified random sample of 953 ≥ 65 was drawn, with a deliberate over-
sampling of those over 80
Patient characteristics and set-
ting
The total population of Kwanak district was 533,577, of whom 4% of the population was ≥ 65.
67.5% of the invited population participated ( N = 643). Of these, 66% were women. 32% were
65-69 (the largest age band). 43.4% had no education, 35.3% had 1-6 years of education and 21.
3% had ≥ 7 years of education. The mean MMSE score in from the participants was 21.5
Index tests Korean MMSE (validated)
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-IV
Flow and timing A stratified sample of those in phase I (index test stage) were invited to phase II (reference standard)
by a neurologist. 307 were drawn from across the scores on the index test to have the reference
standard
Comparative
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Notes No2 x 2 datawere presented.We contacted the authors for this information but received no response
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
No
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
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Lee 2002 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Li 2006
Study characteristics
Patient sampling Subjects were randomly selected elderly Chinese Singaporeans. Exclusions were for head trauma,
stroke, evidence of cerebrovascular disease, neurological disease, systemic illness or unstable medical
conditions that were judged as having a possible effect on the tested aspects. Also excluded were
those using, or with a history of using benzodiazepines or barbituates
Patient characteristics and set-
ting
2/3 subjects were drawn from the community and 1/3 from secondary care. Subjects were 65-90
with normal hearing and vision. 50.7% female with the majority of subjects between 70-75
Index tests MMSE offered in both Chinese (validated) and English
Target condition and reference
standard(s)
Alzheimer’s disease diagnosed according to NINCDS-ADRDA and MCI as diagnosed by CDR
Flow and timing The test battery was performed all at once, including the reference standard
Comparative
Notes Data were presented of diagnostic accuracy for MCI and MCI and AD together, but not for AD
separately. We wrote to the authors for this data but received no response
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
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Li 2006 (Continued)
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
High
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Lindesay 1997
Study characteristics
Patient sampling Random sample of age ≥ 65 registered with GP in Leicester
Patient characteristics and set-
ting
Community-based sample of people aged > 65 in Leicester, UK
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Lindesay 1997 (Continued)
Index tests MMSE
Target condition and reference
standard(s)
All dementia. ICD-10
Flow and timing The time between 1st and 2nd interviews was median 9 weeks. Full psychiatric assessment and
reference standard was restricted to those who scored less than 22, or who had a CARE-D score
(depression rating) of > 7 on first screen and a random third of the rest
Comparative
Notes 2 x 2 data were only available stratified by ethnic origin. We wrote to the authors to ask for un-
stratified data but received no response. The data that were presented were “weighted according to
the sampling fraction at second stage diagnostic interview”: 74 of total 207 Gujarati people sampled
(149 participating) and 59 of total 185 white people sampled (148 participating)
Optimal cut point of MMSE to detect
• Moderate or Severe dementia (definite)
◦ For Gujarati participants: cut point 18, sensitivity 67%, specificity 82%
◦ For white participants: cut point 18, sensitivity 100%, specificity 93%
• Mild, Moderate or Severe dementia (definite)
◦ For Gujarati participants: cut point 18, sensitivity 67%, specificity 82%
◦ For white participants: cut point 20, sensitivity 100%, specificity 97%
• Mild, Moderate or Severe dementia (possible or definite)
◦ For Gujarati participants: cut point 21, sensitivity 73%, specificity 69%
◦ For white participants: cut point 23, sensitivity 91%, specificity 80%
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
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Lindesay 1997 (Continued)
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Liu 1996a
Study characteristics
Patient sampling A representative population of San-Ming district in Kaohshiung City (an industrial port in Southern
Taiwan) - 20 of 86 administrative areas were chosen and then 60 participants randomly from each
area. This was a sample of 1200 people [of whom 1016 were interviewed] representing 12,356
people aged ≥ 65 years
Patient characteristics and set-
ting
535 men, 481 (47%) women, 72.3% were aged 65-74. 42.6% were illiterate. 29.4% had been to
elementary school. 28% had been to high school. Overall prevalence of dementia 4.4%
Index tests Validated version of Chinese MMSE. “Scores were below 17 in the illiterate group, below 21 in the
elementary school educated group, and below 25 in the high school educated group.” The review
authors take the previous sentence to be the cut points for the 3 groups; however, due to ambiguity
in the language this is not entirely clear
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Liu 1996a (Continued)
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III
Flow and timing Of the 1200 sampled, 1016 were interviewed: 50 refused, 91 couldn’t be contacted, 30 had changed
address, 9 were sick and 4 were deceased
All those screening positive on CMMSE went on to receive full clinical diagnosis along with a 5%
sample of those screening negative
If participants performed poorly on the CMMSE (lower than cut point + 2), a proxy (usually a close
relative or caregiver) was interviewed for the Blessed Dementia Rating Scale and questionnaires
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Liu 1996a (Continued)
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Lourenco 2006
Study characteristics
Patient sampling A convenience sample of those over 65 who presented at outpatient primary care clinic. We have
confirmed that this meets the definition of primary care in the protocol
Patient characteristics and set-
ting
Primary care patients aged ≥ 65, poorly educated [only 4.3% had more than 8 years of schooling].
Low socioeconomic status. 26.4% illiterate
Index tests MMSE, validated and modified Portuguese version
Target condition and reference
standard(s)
All dementia. Diagnosed according to DSM-IV and ICD-10
Flow and timing A research assistant trained in conducting MMSE gave index test. The geriatricians and neuropsy-
chologists made a formal diagnosis according to ICD-10 and DSM-IV
Comparative
Notes 20 (6.6%) of participants had suffered a stroke and 57 (18.8%) had depression
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Lourenco 2006 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
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Macedo Montano 2005
Study characteristics
Patient sampling Participant survivors of a cohort who were ≥ 65 years and residing in Sao Paolo, Brazil when
recruited 7 years previously
Patient characteristics and set-
ting
Community setting, > 72 years old in Sao Paolo, Brazil
Index tests MMSE, presumably translated into Portuguese (not stated)
Target condition and reference
standard(s)
Dementia according to DSM-IV and NINCDS-ADRDA
Flow and timing Timing unclear. All elderly scoring < 26 received reference standard along with a sample of the rest
Comparative
Notes The quality of reporting in this paper made it difficult to make judgement on the risk of bias. We
have concerns about the quality of conduct
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Unclear
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Macedo Montano 2005 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Mackinnon 2003
Study characteristics
Patient sampling Probability sample of persons aged ≥ 70 years drawn from the electoral roll for Canberra and the
neighbouring town of Queanbeyan and stratified to recruit equal numbers of male and female
Patient characteristics and set-
ting
Asymptomatic community ≥ 70 in Australia
Index tests MMSE
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing Participants were interviewed in their homes by lay interviewers. MMSE was administered as part
of the interview. Diagnosis according to DSM-III-R was made using information from interviews
after completion of all interviews
Comparative
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Mackinnon 2003 (Continued)
Notes Of 945 participants, interviews including the IQCODE could be obtained for 694 participants.
The MMSE scores were not available for 48 participants. Diagnoses of dementia could not be made
for 19 persons. The analyses presented here were undertaken on 646 participants for whom all data
was available
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
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Mackinnon 2003 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Maki 2000
Study characteristics
Patient sampling 1438 participants were invited (the entire > 65 population of the town), of whom 1255 agreed to
take part. Those who lived alone were excluded due to lack of informant, leaving 818. The data
were presented for 662 subjects
Patient characteristics and set-
ting
Elderly general population > 65 in in rural community of Nakayama town in Ehime, Japan
Index tests MMSE (we presume a Japanese version - not reported)
Target condition and reference
standard(s)
All dementia diagnosed according to DSM-III-R
Flow and timing The paper says that “we analysed data from 818 subjects for this paper” but in fact, data is only
presented for 662 people, and no reason is given for this discrepancy. 258 subjects were selected for
the clinical evaluation using at least 1 of the following criteria 1) MMSE score of ≤ 23, 2) SMQ
(validated short memory questionnaire) score of ≤ 39/46, 3) Karasawa scale score of ≥ 1 and, 4) 0
score on 3-word recall. Additionally, they reselected 50 of the remaining 560 at random to undergo
reference standard. This totals 308. We cannot see where the total of 662 has come from. Timing
of tests is not clear
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Maki 2000 (Continued)
Did the study avoid inappropri-
ate exclusions?
No
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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Mingyuan 1998
Study characteristics
Patient sampling The study population was based on a study conducted in 1987. In 1987, a total of 5055 people
were included and according to the DSM-III-R , 159 of the 5055 had dementia, 4896 of the 5055
were normal
In 1992, the 4896 people were investigated again, and 792 died, 1080 were lost to follow-up, so
3024 people were involved in the present study
Patient characteristics and set-
ting
57.34% female
Index tests MMSE (we presume CMMSE, but no information about validation is given)
Target condition and reference
standard(s)
Dementia according to DSM-III-R
Flow and timing Reference standard was given to 711 participants whose MMSE were positive (the total score was
lower than the cut point whichwas based on the education level) and 321 participants whoseMMSE
were negative (stratified sampling)
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
No
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Mingyuan 1998 (Continued)
study?
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
MoVies Study 1993
Study characteristics
Patient sampling The validation sample for this studywas an age-stratified random sample drawn from a population of
more than 17,000 older adults in 23 communities of the mid-Monongahela Valley of Southwestern
Pennsylvania (the MoVIES sample, initiated in the early 1990s)
Patient characteristics and set-
ting
Participants were English speakers aged ≥ 65 (mean age 73.1), with at least 6 years of formal
education (median education was high school graduate), living in the community (southwestern
Pennsylvania). 96.6% white, 54.6% female, 56.9% married and 31.1% living alone
Index tests Standard MMSE
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R. There is concern about the conduct of the reference
standard. There were 2 stages, in the first instance, trained non-specialists gathered information and
a psychiatrist made a tentative diagnosis. Those who were identified as not demented in this initial
diagnosis were not evaluated further. People who were identified as possibly or probably demented
were evaluated by a specialist. Some cases of dementia may not have been identified
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MoVies Study 1993 (Continued)
Flow and timing It is unclear how many of the entire group received the reference standard. The reference standard
comprised 2 stages: in the first instance, trained non-specialists gathered information and a psychia-
trist made a tentative diagnosis. Those who were identified as not demented in this initial diagnosis
were not evaluated further. People who were identified as possibly or probably demented were eval-
uated by a specialist. Some cases of dementia may not have been identified. From the way that the
data is presented, we can work out patient flow through index test and reference standard. However,
we are confident that all test positives and some test negatives received the reference standard
Comparative
Notes Data presented are drawn from multiple papers relating to the MoVies study, largely Borson 2003
and Ganguli 1993. We have contacted the authors to try to reconcile some differences in data
presented, particularly regarding sample size and flow of participants, but unfortunately, they were
unable to clarify
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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MoVies Study 1993 (Continued)
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Pandav 2002
Study characteristics
Patient sampling Population-based, largely illiterate sample of 5126 individuals aged ≥ 55 in 28 villages in the rural
community of Ballabgarh in northern India out of a total population of 5134
Patient characteristics and set-
ting
Population-based, largely illiterate (73.3%) sample of 5126 individuals aged ≥ 55 in 28 villages in
the rural community of Ballabgarh in northern India. 95.4% of women were illiterate, as were 53.
8% of men. Illiteracy was defined by inability to read a local newspaper and write a sentence
Index tests HMSE (Hindi Mental State Examination) being validated in this study
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing Of the 5126 subjects who were thus cognitively or functionally screened, 536 (10.5%) were selected
as screen-positives for standardised clinical diagnosis and a random sample of 270 (5.3%) were
selected as screen negatives to also undergo standardised clinical diagnostic evaluation
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
112Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community
and primary care populations (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pandav 2002 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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PAQUID Study
Study characteristics
Patient sampling A random sample of 4050 was drawn according to a 3-stage sampling design. The first 2 stages
resulted in the selection of 37 parishes distributed across Gironde, France. Subjects were then
randomly selected from the electoral lists after stratification by age and sex
Patient characteristics and set-
ting
2792 subjects 65 years and older living independently in Gironde, France. The age and sex distri-
bution for the sample was similar to the overall target population. 22.2% of men (619) were aged
65-74, 14.9% of men (417) were aged 75-84, 3% (84) were over 84 (total 1120 men). 28.1% (784)
were aged 65-74, 23.9% (667) were aged 75-84, 7.9% (221) were aged > 84 (total 1672 women)
Index tests We assume that the MMSE was conducted in French. There was no data given as to a validated
translation
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III
Flow and timing All 2792 subjectswere administered psychometric tests (includingMMSE) at homeby a psychologist
and applied the DSM-III diagnostic criteria
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
Unclear
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PAQUID Study (Continued)
study?
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
Yes
Phantumchinda 1991
Study characteristics
Patient sampling A random sample of 500 people > 60, resident in a large urban slum, Klong Toey, Bangkok. Had
to have lived in the slum for over a year and willing to take part. Interviewed the elderly subjects
and their close relatives. Started in 1989
Patient characteristics and set-
ting
Low socioeconomic status. 41% are aged 60-64; 26% are aged 65-69; 17% aged 70-74. Only 6.
2% were > 80. Low education: 87.4% had < 4 years of education
Index tests Field survey version of the MMSE, translated into Thai (non-validated version)
Target condition and reference
standard(s)
Dementia according to DSM-III-R
Flow and timing Everyone was seen by a physician. Those thought to have dementia were then seen by a neurologist
for confirmation. More confident in the determination of true positives. 500 out of 588 agreed to
take part
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Phantumchinda 1991 (Continued)
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
Yes
Pond 1994
Study characteristics
Patient sampling “All GPs conducting clinics at a large retirement village complex in Sydney, Australia, were ap-
proached to take part in this study, provided that they had at least 10 patients aged 70 or over who
were living either independently or in hostel accommodation . .
”During the pre- and post-intervention sampling phases each GP completed a 1 page questionnaire
for each patient attending and recorded his/her opinion on the dementia status of each of these
patients, aswell as an opiniononwhether the patientwas depressed or not. The reasons for attendance
were recorded as were major chronic illnesses . .
“Of the 258 patients approached in the pre-intervention sample, 45 refused and 13 were excluded
due to illness (12 physical illness; 1 probable depression), while 200 had a home interview, of
which 105 had the additional CIE assessment. In the post-intervention sample, 218 patients were
approached. Of these, 50 refused, 1 was excluded due to physical illness, and 167 had a home
interview, including 69 who completed the CIE.”
Patient characteristics and set-
ting
Pre-intervention (academic training)
Age 82.5 years (SD 5.9)
Mean MMSE 26 (SD 3.7)
86% female
66% Hostel
Post-intervention
Age 82.9 years (SD 6.1)
MMSE 25.9 (SD 3.6)
88% female
73% Hostel
Hostels are “low level residential care”
Index tests MMSE administered in the patient’s own home by a trained nurse
Target condition and reference
standard(s)
Dementia, DSM-III-R and ICD-10 ’probable dementia’ diagnoses
Flow and timing “Patients who agreed to join the study were then, within a week of their consultation, interviewed
in their own home by a registered nurse . . . A 1 in 2 subsample received an abridged version of the
Canberra Interview for the Elderly (CIE),19 a structured interview with an informant component.
The CIE enables the generation of a set of diagnoses for each patient based upon the DSM-III-
R classification system and the draft International Classification of Diseases, version 10 (ICD-10).
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Pond 1994 (Continued)
Selection for the CIE subsample was random, taking every second consecutive case.”
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
No
Low
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DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Ramlall 2013
Study characteristics
Patient sampling A convenience sample of 302 residents in a non-governmental home for the elderly housing in
Durban, South Africa. A total of 1371 residents and those receiving frail care in assisted and
independent living for people aged ≥ 60 years
Patient characteristics and set-
ting
Inclusion criteria were residents who were aged ≥ 60 years, had a minimum of 8 years of formal
schooling, were able to speak, read and write in English and gave written informed consent. Exclu-
sion criteria were residents with severe physical, mental or sensory handicap that precluded their
engagement with the assessment
Given these inclusion (informed written consent) and exclusion criteria, we have concerns that those
most severely affected by dementia will be excluded from the study. We anticipate that this would
result in an underestimation of the diagnostic utility of the test
Index tests MMSE
Target condition and reference
standard(s)
Dementia diagnosed according DSM-IV-R
Flow and timing 302 were convenience sampled. Of those, 38 screen positives and 102 randomly selected screen
negatives had a clinical diagnostic evaluation
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Ramlall 2013 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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Rosselli 2000
Study characteristics
Patient sampling The sample was obtained from the 5 principal urban conglomerates of Colombia (Bogota, Medellin,
Cali, Barranquilla, Bucaramanga) according to the 1993 census. In each of these regions, sampling
was carried out as follows
1. A random neighbourhood was selected with the numbers generated by a computer.
2. A second neighbourhood, again done randomly, obtained a small local area 2 hours or less
from each of the 5 mentioned cities.
3. A third sample of the rural population was chosen randomly in another similar municipal.
The sample was representative of Colombia as a whole.
Patient characteristics and set-
ting
Visited 2560 homes and interviewed 9328 participants, of those, 1949 were > 50 years old. 1686
individuals responded toMMSE, but 75were excluded because they died or only partially completed
3 or more questions. In total 1611 were included
613 were male = 38.1%
998 were women = 61.9%
Average 3 years education
Mean age = 62.9 years
Given that the review is looking at the utility of the test in adults over the age of 65, we have marked
the applicability of the population as ’of high concern’
Index tests Translated version of the MMSE. The cut points were adjusted for education as follows: ≤ 21 for
< 6 years schooling; < 24 for 7-12 years of schooling; < 27 for those with > 12 years of schooling
For individuals older than 65 years of age an additional point was added to the total mark
For those older than 75, 2 additional points were added to the total mark
Participants with visual limitation also received 2 additional points
Target condition and reference
standard(s)
Dementia, DSM-IV
Flow and timing People who scored below a cut point were evaluated by a clinician, together with a 5% random
sample of ’healthy’ participants
Of the 1611 participants, 536 who scored below education adjusted cut point (33.3%), 209 of
these individuals suspected of possible dementia did not attend, so 327 completed evaluation. The
average MMSE score of people who did not attend (19.05 ± 3.72) was statistically higher than the
MMSE score of people who did attend (16.38 ± 4.54) P < 0.001. Of the 327 who completed the
reference standard, 12 had dementia
Of the 1075 participants with satisfactory scores on MMSE, 366 (34%) were seen by a neurologist
for other reasons, and 1 of these was found to have dementia
Comparative
Notes Translated by Mr William Eustace on 30 October 2014
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Rosselli 2000 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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Rummans 1996
Study characteristics
Patient sampling A population-based, age-stratified, random sample of residents of Rochester, Minnesota, USA aged
≥ 65
Patient characteristics and set-
ting
406 people were sampled and contacted, of whom 201 agreed to participate. 65% were female. The
mean age was 78.3 for men and 80.2 for women
Index tests MMSE with standard cut-off of 24 indicating normality, combined with AVLT
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing Patients scoring 23 or below on MMSE or failing the other screens (22 in total) went on to receive
reference standard, along with 15 who passed all screens
Comparative
Notes Sensitivity and specificity is presented for MMSE and AVLT combined (92.3% and 100% respec-
tively) in the paper. We contacted the authors for the separate data for MMSE only and received
no response
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
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Rummans 1996 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Scazufca 2009
Study characteristics
Patient sampling Participants were those enrolled in the baseline assessment of the Sao Paulo Ageing andHealth Study
(SPAH). The investigation was carried out in the borough of Butantã, located on the west side of
the city. Between May 2003 and April 2005 all residents aged ≥ 65 years living in 66 census sectors
of the Butantã borough, covering a population of approximately 63,000 residents, were invited to
participate in the SPAH. A total of 2072 persons (91.4% of those invited) were recruited through
systematic door knocking. Interviews for the assessment of dementia took place at participants’
residences approximately 1 week after recruitment
Patient characteristics and set-
ting
Populationbased. 60.6% female, 43%aged65-69, 27%aged70-74, 38.5%had 0years of education.
50% had a personal income of < USD 127 per month
Index tests Validated version of the Brazilian version of the MMSE
Target condition and reference
standard(s)
Dementia according to DSM-IV
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Flow and timing A total of 2072 persons were recruited. Included in the analysis were 1933 participants (93.3% of
those assessed for the prevalence study). Among the 139 participants excluded, 48 were unable to
answer ≥ 5 items of the questionnaire due to severe physical or mental impairment (18 cases of
dementia, 20 subjects with sensory impairments - eye or hearing
problems, 10with other physical incapacities), 10were approached but refused to answer theMMSE
questions, and 81 were not approached by the research team for the battery of assessments that
included the MMSE
Comparative
Notes Reference standard was DSM-IV applied by algorithm rather than by a psychiatrist or neurologist.
Data is only presented for the diagnostic accuracy of the MMSE stratified by educational level
(none, 744 participants; ≥ 1 year, 1189 participants). There were 84 people with dementia out of
a total of 1933. Because we do not know the number of people with dementia in these 2 groups,
despite attempting to contact the authors, it is not possible to enter the data separately and so the
study cannot be included in the meta analysis
No education cut points
14 indicating normal sensitivity 72.3% specificity 84.9%
15 indicating normal sensitivity 78.7% specificity 77.8%
16 indicating normal sensitivity 87.2% specificity 70.4%
17 indicating normal sensitivity 93.6% specificity 61.3%
18 indicating normal sensitivity 93.6% specificity 49.1%
19 indicating normal sensitivity 95.7% specificity 40.2%
20 indicating normal sensitivity 97.9% specificity 29.7%
≥ 1 year(s) of education cut points
18 indicating normal sensitivity 91.9%, specificity 89.5%
19 indicating normal sensitivity 91.9%, specificity 85.4%
20 indicating normal sensitivity 94.6%, specificity 78.8%
21 indicating normal sensitivity 94.6%, specificity 69.9%
22 indicating normal sensitivity 94.6%, specificity 59.9%
23 indicating normal sensitivity 94.6%, specificity 50.6%
24 indicating normal sensitivity 100%, specificity 37.6%
25 indicating normal sensitivity 100%, specificity 27.8%
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
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Scazufca 2009 (Continued)
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
No
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Were all patients included in the
analysis?
No
Schultz-Larsen 2007
Study characteristics
Patient sampling The study sample was drawn from respondents to the so-called Brønshøj-Husum Study, a 3-stage
population study of dementia and functional ability among all community-dwelling elderly women
(1147) and men (635) born between 1913 and 1918 and living in a district of Copenhagen in
January 1994
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Patient characteristics and set-
ting
65% had ≤ 7 years education, 64% were women in phase 1 sample and 53.5% women at stage 2.
Average age was 79 in whole sample and 80.2 in the phase 2 sample. 56% lived alone
Index tests Standardised Danish version of the original MMSE
Target condition and reference
standard(s)
Dementia according to DSM-IV
Flow and timing In the first stage of the study, 67% (759 women and 430 men) of the population underwent a
baseline
and cognitive assessment in their homes by a trained research nurse using standard instruments
including the
MMSE.
In the second stage, a subsample of initial respondents was asked to undergo a clinical neuropsy-
chological examination. The subsample included all subjects who screened positive (MMSE < 26
among subjects with 7 years of schooling, < 27 for subjects with longer education) at the baseline
assessment (N = 156) besides a random sample of individuals stratified by age and sex (N = 164)
among subjects who screened negative at the baseline assessment
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
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Schultz-Larsen 2007 (Continued)
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Tang 1999
Study characteristics
Patient sampling Participants were cluster sampled by draw from different districts of Chengdu, China
Patient characteristics and set-
ting
Participants were 55.79% female and had a mean age of 67.12. 53.96% (648) of the participants
were from downtown; 26.56% (319) were from rural-urban continuum; 19.48% (234) were from
rural settings. The education level of the participants who lived downtownwere the highest, followed
by the participants who lived in the rural areas. The participants living in the rural-urban continuum
had the lowest educational levels
Index tests Chinese version of MMSE but no validation information given
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing Not all participants received the reference standard.
1. Those whose score of the CMMSE below the criteria (illiterate group: CMMSE ≤17 primary
school group: CMMSE ≤20, middle school and above CMMSE ≤24) had the reference standard
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2. Those whose score of the CMMSE was normal, but the doctor or family member suspected
dementia had the reference standard
3. To avoid the missed diagnoses, 20% of the participants in the illiterate group whose CMMSE
score were 18 or 19 were randomly selected to have the reference standard
4. 4% of the participants whose CMMSE score were normal were also randomly selected to have
the reference standard
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
No
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
Yes
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study?
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
West Beijing Study 1989
Study characteristics
Patient sampling All the households with residents aged ≥ 60 years in the West district of Beijing, specifically 4
communities in the west district of Beijing
Patient characteristics and set-
ting
585 females, 505 males. 33.7% illiterate. Illiteracy in women 53.8%. 60.8% of those who had been
employed were workers in service industry. 36.2% were professional or administrative workers. 51.
2% of women and 17.1% of men were widowed. 70% lived with their children
Index tests The MMSE was translated into Chinese from English, with each item being discussed with a
neuroepidemiologist from the United States, the late Professor B. Schoenberg
Target condition and reference
standard(s)
Dementia according to DSM-III (slightly modified). Criterion A was thus extended to be “loss
of intellectual ability of sufficient severity to interfere with daily living, social and occupational
functioning of a sufficient degree that help is needed on a day-to-day basis either part or all of the
time”
Flow and timing N = 1090. Only 1072 receivedMMSE, of those, all those who scored≤ 17 onMMSE (n = 42) plus
a randomised sample of 5.5% (57 participants) of the rest received the full clinical examination.
The 18 people who couldn’t undergo an MMSE were screened using a different test, the Crichton
Scale
Comparative
Notes The overall prevalence of dementia was calculated as 1.3%
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
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Wilder 1995
Study characteristics
Patient sampling Patients were recruited from the North Manhattan Aging Project by census
Patient characteristics and set-
ting
Urban setting, Manhattan, USA. 790 people in total. 355 Latino, 299 African American and 136
white. 39% were aged 78-84, 46% had 5-11 years of education
Index tests MMSE with some translations in real-time for non-native speakers of English
Target condition and reference
standard(s)
Dementia diagnosed according to DSM-III-R
Flow and timing No information about timing given. All screen positives and a portion of screen negatives were
referred for reference standard
Comparative
Notes We contacted the authors for 2 x 2 data and received no reply so are unable to include this study in
the meta-analysis
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Low
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
No
Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Winblad 2010
Study characteristics
Patient sampling A total population based clinico-epidemiological study was carried out covering all of the 1680
inhabitants aged ≥ 60 in the rural municipality of Haapajarvi in Northern Finland. Registers of
health and social welfare and population interviews were used
Patient characteristics and set-
ting
Aged ≥ 60 in the rural municipality of Haapajarvi in Northern Finland. We have concerns about
the applicability due to the exclusion of previously diagnosed dementia patients
Index tests MMSE assumed to be in Finnish. No information about validation of the translation. There is no
reference at all to the index test, including the original Folstein paper
Target condition and reference
standard(s)
All-cause dementia diagnosed according to DSM-IV
Flow and timing The total ≥ 60 population was 1680, they did a first stage dementia awareness campaign. They
took a random sample of 840, excluding those who they had seen at the campaign, which left 757,
of whom 490 proceeded to index test
Of the 490 who received the index test, they performed reference standard on 114 people. The
reference standard was performed on 82 out of 110 (75%) of those who scored < 25 on MMSE.
The reference standard was performed on 32 out of 380 (8.4%) of those who scored 25 or more on
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MMSE
Comparative
Notes -
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
High
DOMAIN 2: Index Test All tests
If a threshold was used, was it
pre-specified?
Yes
Were sufficient data on MMSE
application given for the test to
be repeated in an independent
study?
No
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Was sufficient information on
the method of dementia assess-
ment given for the assessment to
be repeated in an independent
study?
Yes
Low
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DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
3MS: Modified Mini-Mental State Examination; AD: Alzheimer’s disease; ADL: activities of daily living; ADRDA: Alzheimer’s Disease
and Related Disorders Association; AMT: Abbreviated Mental Test; AVLT: Auditory Verbal Learning Test; CDR: clinical dementia
rating; CIE: Canberra Interview for the Elderly;CMMSE: ChineseMini-Mental State Examination; CSI-D: Community Screening
Instrument for Dementia;DSM: Diagnostic and Statistical Manual of Mental Disorders;GPCOG: General Practitioner Assessment
of Cognition; ICD: International Classification of Diseases; IQCODE: Informant Questionnaire on Cognitive Decline in the
Elderly; LTCI: long-term care institution; MCI: mild cognitive impairment; MMSE: Mini-Mental State Examination; NCI: no
cognitive impairment; NINCDS: National Institute of Neurological and Communicative Disorders and Stroke; PCP: primary care
practitioner; SIDAM: Structured Interview for Diagnosis of Dementia of the Alzheimer Type; SMQ: short memory questionnaire;
SPMSQ: Short Portable Mental Status Questionnaire.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Al-rajeh 1999 Wrong setting (secondary care)
Almeida 1998 Wrong setting (secondary care)
Basic 2009 Wrong setting (secondary care)
Bastide 2012 Wrong setting (secondary care)
Belmin 2007 Wrong setting (secondary care)
Bermejo 1999 Wrong setting (secondary care)
Bermejo-Pareja 2009 Wrong index test (37-item MMSE)
Bland 2001 Wrong index test (3MS, not MMSE)
Borson 1999 Wrong study design (case-control)
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Borson 2000 Wrong study design (case-control)
Borson 2005 Wrong study design (case-control)
Braekhus 1995 Wrong study design (case-control; all participants pre-diagnosed as non-dementia patients)
Brooke 1999 Wrong setting (secondary care)
Burnham 2012 Wrong setting (secondary care)
Cacho 2010 Wrong setting (secondary care)
Canadian Study of Health and Aging Wrong index test (3MS)
Cao 2012 Wrong setting (secondary care)
Carpenter 2011 Wrong setting (secondary care)
Cercy 2012 Wrong study design (case-control)
Cerveira 2009 Wrong setting (secondary care)
Cervilla 2004 Wrong study design (only those scoring 25 or less received reference standard - partial veri-
fication)
Chaves 2007 Wrong setting (secondary care)
Chaves 2009 Wrong reference standard (none; prevalence study only)
Chester 2011 Wrong reference standard (none)
Chong 2010 Wrong study design (case-control)
Clark 1999 Wrong study design (case-control; all patients had pre-diagnosed cognitive impairment)
Clarke 1991 Wrong reference standard (CAMDEX with no reference to DSM)
Cossa 1997 Wrong study design (only index test positives received the reference standard)
Cossa 1999 Wrong study design (partial verification - reference standard applied only to those with
positive index test result)
Costa 2012 Wrong study design (not diagnostic test accuracy study)
Cullen 2005 Wrong reference standard
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Dahl 2007 Wrong study design (partial verification - only index test positives received reference standard)
Damian 2011 Wrong setting (secondary care)
Dash 2006 Wrong setting (secondary care)
Davous 1988 Wrong reference standard (None)
De Beaman Wrong setting (secondary care)
De Jager 2009 Wrong study design
De Silva 2002 Wrong reference standard (CAMCOG)
Del-Ser 1997 Wrong setting (secondary care)
Derrer 2001 Wrong study design (case-control)
Dierckx 2011 Wrong study design
Diniz 2007 Wrong setting (secondary care)
Dong 2012 Wrong setting (secondary care)
Donnelly 2008 Wrong reference standard
Drachmann 1996 Wrong study design (case-control; drawn from partially secondary care population)
Duron Wrong target condition (dementia not key outcome)
Fabrigoule 1995 Wrong study design
Feher 1992 Wrong setting (secondary care)
Fernandez-Martinez 2008 Wrong study design (partial verification - only index test positives received reference standard)
Fernandez-Martinez 2010 Wrong setting (secondary care)
Ferrero-Arias 2001 Wrong setting (secondary care)
Ferruci 1998 Wrong setting (secondary care)
Fong 2010 Wrong setting (secondary care)
Forlani Wrong index test (not looking at accuracy of MMSE)
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Fountoulakis 1998 Wrong study design (case-control)
Fountoulakis 2000 Wrong study design (case-control)
Fratiglioni 1993 Wrong index test (not looking at accuracy of MMSE)
Fratiglioni 1994 Wrong index test (not looking at accuracy of MMSE)
Fujiawara 2003 Wrong study design (case-control; all patients had cognitive decline)
Gabryelewicz 2002 Wrong study design (partial verification - only index test positives received reference standard)
Galvin 2010 Wrong setting (prevalence of dementia over 60%. Secondary or tertiary care setting.)
Ganguli 2004b Wrong study design (partial verification - only index test positives received reference standard)
Ganguli 2010a Wrong study design (partial verification - only index test positives received reference standard)
Ganguli 2010b Wrong study design (partial verification - only index test positives received reference standard)
Ganzer 2003 Wrong setting (secondary care)
Garcia Wrong study design (case-control; all healthy participants at baseline)
Garcia 1993 Wrong reference standard (MMSE is the reference standard)
Geerlings 1999 Wrong study design (no DTA data)
Gibbons Wrong setting (secondary care)
Goldman 2001 Wrong index test (no MMSE in study)
Gondo 2006 Wrong reference standard (none)
Grigoletto 1999 Wrong study design (case-control; excluded those with symptoms)
Grober 2008 Wrong study design (case-control; excluded those with MMSE score < 18)
Harder 1995 Wrong study design (case-control)
Hartmann 2002 Wrong setting (secondary care)
Hashizume 2004 Wrong setting (secondary care)
Helkala 2002 Wrong study design (partial verification - only those scoring <24onMMSE received reference
standard)
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Hensel 2009 Wrong study design (case-control; excludes participants with dementia symptoms)
Hogervorst Wrong study design
Holsinger 2012 Wrong index test (3MS data presented - no MMSE extracted)
Huppert 2005 Wrong study design (no test accuracy data)
Ibrahim 2009 Wrong study design
Ideno 2012 Wrong study design
Ihl 2005 Wrong study design (case-control)
Jagger 1992 Wrong reference standard
Jeong 2007 Wrong study design (case-control; excludes cognitively impaired)
Jervis 2007 Wrong study design (not a test accuracy study)
Jeste 1992 Wrong study design (case-control)
Jones 2010 Wrong setting (secondary care)
Jonsson 2010 Wrong study design (not a test accuracy study)
Jorm 1996 Wrong reference standard
Jorm 1997 Wrong study design (not a test accuracy study)
Kal’bus Wrong study design (participant ages 35-65)
Kamenski 2009 Wrong reference standard (none)
Kanegae 2008 Wrong setting (secondary care)
Kaufer 2008 Wrong setting (secondary care)
Khachaturian 2000 Wrong index test (3MS)
Kirby 2001 Wrong reference standard (AGECAT with no reference to DSM)
Kliegel 2004 Wrong reference standard (none)
Kochhann 2010 Wrong study design
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(Continued)
Koski 2011 Wrong setting (secondary care)
Koson Wrong study design (patients scoring < 24 on MMSE excluded)
Krigbaum 2012 Wrong study design (case-control)
Kukull 1994 Wrong study design (case-control; only dementia patients)
Kuslansky 2004 Wrong study design (case-control)
Lam Wrong study design (looking at change in MCI)
Lam 2005a Wrong reference standard (only CDR 0.5)
Lam 2005b Wrong study design (no DTA data)
Larner 2012 Wrong setting (secondary care)
Larson 1984 Wrong setting (secondary care)
Lautenschlager 1986 Wrong setting (secondary care)
Law 1995 Wrong index test (3MS)
Lee Wrong study design (prevalence of cognitive impairment)
Lee 1997 Wrong study design (partial verification; only index test positives received reference standard)
Lee 2009 Wrong study design (partial verification; only index test positives received reference standard)
Leoutsakos 2012 Wrong study design (case-control; all participants had AD)
Li 2009 Wrong study design (partial verification; only index test positives received reference standard)
Li 2013 Wrong setting (secondary care)
Limpawattana 2012 Wrong setting (secondary care)
Lin 1998 Wrong study design (partial verification; only index test positives received reference standard)
Liu 1994 Wrong index test (CASI)
Liu 1995 Wrong study design (partial verification; only index test positives received reference standard)
Liu 1996b Wrong study design
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(Continued)
Liu 1998 Wrong study design (partial verification; only index test positives received reference standard)
Llibre 2009 Wrong study design (prevalence study)
Lobo 2008 Wrong study design
Lopes 2010 Wrong study design (case-control; only those with cognitive impairment)
Lopez-Pousa 1995 Wrong reference standard
Luis 2009 Wrong study design
MacKenzie 1996 Wrong study design
MacKnight 1999 Wrong index test (3MS)
MacNeill 2000 Wrong setting (secondary care)
Marcos de Vega Wrong target condition (MCI)
Medina Wrong study design (not DTA; no MMSE accuracy data)
Meguro 2007 Wrong study design (case-control; wrong patient population)
Molloy 1997 Wrong study design (not a DTA study)
Moretti Wrong target condition (MCI)
Mungas 1996 Wrong study design
Murden 1991 Wrong study design
Murden 1997 Wrong study design (case-control; wrong participant population)
Nadler 1995 Wrong setting (secondary care)
Narasimhalu 2008 Wrong setting (secondary care)
Neri 2001 Wrong study design (partial verification; only index test positives received the reference
standard)
Ng 2007 Wrong reference standard
Nishiwaki 2004 Wrong reference standard
Noale 2006 Wrong study design (delayed verification)
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Nourhashemi 2008 Wrong study design (case-control; wrong population)
O’Bryant 2008 Wrong study design
O’Connor 1989 Wrong study design
Olazaran 2004 Wrong target condition (MCI)
Onishi 2006 Wrong setting (secondary care)
Ostrosky-Solis 1999 Wrong study design (case-control)
Pachet 2010 Wrong study design
Pardo 1990 Wrong study design (case-control)
Perneczky 2006 Wrong setting (secondary care)
Pezzotti 2008 Wrong study design (case-control; participants with cognitive impairment only)
Pouretemad 2009 Wrong study design
Qu 2005 Wrong study design (partial verification.Only index test positives received reference standard.
)
Quiroga 2004 Wrong study design (case-control)
Rabins Wrong study design
Rai 1998 Wrong setting (secondary care)
Rai 2008 Wrong setting (secondary care)
Raina 2013 Wrong study design (case-control)
Rait 2000 Wrong reference standard
Raskind 1999 Wrong study design (No MMSE test accuracy data)
Riedel-Heller 1999 Wrong study design (case-control; only healthy participants)
Roelands 1992 Wrong study design (only index test positives received the reference standard)
Schrijnemaekers 2006 Wrong study design (case-control)
Sikkes 2013 Wrong study design (case-control)
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Spering 2012 Wrong study design
Stewart 2002 Wrong study design (normative study)
Stoppe Wrong study design
Storey 2002 Wrong setting (tertiary care)
Storey 2004 Wrong study design
Subra 2012 Wrong target condition
Sugishita Wrong index test (short MMSE)
Tae 2010 Wrong study design
Taillandier 2002 Wrong setting (secondary care)
Tamura Wrong study design
Tang-Wai 2003 Wrong setting (secondary care)
Tappen 2012 Wrong setting (mixed recruitment, largely from secondary care)
Tariq 2006 Wrong setting (secondary care)
Tariska 2003 Wrong setting (secondary care)
Thibodeau 2011 Wrong study design (longitudinal change)
Thiele Wrong study design (case-control; all subjects had MCI at baseline)
Tian Wrong index test
Tierney 2000 Wrong setting (secondary care)
Timpano 2013 Wrong setting (secondary care; and case-control)
Tombaugh 1996 Wrong index test (3MS)
Tombaugh 2005 Wrong study design (case-control; all participants had MCI at baseline)
Travers 2013 Wrong setting (secondary care)
Trenkle 2007 Wrong target condition (MCI)
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Tschanz 2004 Wrong study design
Tuokko 1995 Wrong index test (3MS)
Uhlmann 1991 Wrong study design (case-control)
Unger 1999 Wrong study design
Van der Cammen 1992 Wrong setting (secondary care)
Van Exel 2003 No reference standard
Van Sanden 2012 Wrong study design
Vantaa 85+ Wrong study design (case-control; all demented subjects were excluded)
Vas 2001 Wrong study design (case-control; selected population)
Vercambre 2010 Wrong reference test (MMSE is part of the reference standard)
Vigliecca 2012 Wrong study design
Waite 2001 Wrong target condition (cognitive impairment)
Watfa 2001 Wrong study design (case-control; subjects at baseline all in good cognitive health)
Weston 1987 Wrong reference standard (none)
White 2002 Wrong study design (partial verification; only those with positive index tests received reference
standard)
Whitney 2012 Wrong setting (secondary care)
Wolf Klein 1989 Wrong setting (secondary care)
Wrobel 2007 Wrong reference standard
Wu 2002 Wrong study design (partial verification; only index test positives received reference standard)
Wu 2003 Wrong study design (no DTA data presented)
Wu 2006 Wrong study design
Yang 2006 Wrong study design (partial verification; only those with positive index test received reference
standard)
Yavorsky Wrong setting (secondary care)
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(Continued)
Ylikoski 1992 Wrong study design
Yuseph 1997 Wrong study design (not a DTA study)
Zaragoza study Wrong reference standard
Zaudig 1992 Wrong study design (case-control)
Zhang 1998 Wrong study design
Zhang 2012 Wrong study design
3MS: Modified Mini-Mental State Examination; AD: Alzheimer’s disease; CAMCOG: Cambridge cognition examination; CASI:
Cognitive Abilities Screening Instrument; CDR: clinical dementia rating; DSM: Diagnostic and Statistical Manual of Mental
Disorders; DTA: diagnostic test accuracy; MCI: mild cognitive impairment; MMSE: Mini-Mental State Examination.
Characteristics of studies awaiting classification [ordered by study ID]
Gungen 2002
Study characteristics
Patient sampling No information available
Patient characteristics and set-
ting
-
Index tests -
Target condition and reference
standard(s)
-
Flow and timing -
Comparative -
Notes -
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Jianbo 2013
Study characteristics
Patient sampling No information available
Patient characteristics and set-
ting
-
Index tests -
Target condition and reference
standard(s)
-
Flow and timing -
Comparative -
Notes -
Kornsey
Study characteristics
Patient sampling No information available
Patient characteristics and set-
ting
-
Index tests -
Target condition and reference
standard(s)
-
Flow and timing -
Comparative -
Notes -
Kvitting 2013
Study characteristics
Patient sampling A total of 81 participants (≥ 65 years old and living at home) were recruited from 4 primary health
care centres in Sweden between December 2007 and May 2009. Of these patients, 52 exhibited
possible cognitive impairment and 29 were presumed cognitively healthy and visiting primary care
for some other medical problem. All 81 patients were asked to participate in the study during an
appointment with a general practitioner. 1 patient declined
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Kvitting 2013 (Continued)
Patient characteristics and set-
ting
48 women (59%) and 33 men, 77 of the 81 were native Swedish speakers, average age 77.2 years,
average education 10.4 years, duration of cognitive symptoms 1.5 years
Index tests MMSE (we presume a Swedish translation. No reference was given to any validation of the trans-
lation.)
Target condition and reference
standard(s)
Dementia diagnosed according to ICD-10
Flow and timing -
Comparative -
Notes -
Orsi
Study characteristics
Patient sampling No information available
Patient characteristics and set-
ting
-
Index tests -
Target condition and reference
standard(s)
-
Flow and timing -
Comparative -
Notes -
Shaaban 2013
Study characteristics
Patient sampling “This was a cross-sectional study involving 49 Community dwelling elderly age 65 years and above
who attended primary care in Keylantan from January to February 2010. Those who were diagnosed
to have Parkinson’s disease, mental retardation, psychiatric illness and physical handicaps were
excluded.”
Patient characteristics and set-
ting
“A total of 49 respondents were involved in this study. Majority of the subjects were Malay (98%)
and married (88%).” 64% were female and 61% were educated to primary level. Median age was
68 years. “According to DSM-IV criteria 79.6% were normal and 20.4% had dementia.”
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Shaaban 2013 (Continued)
Index tests The Malay version of the MMSE (previously validated)
Target condition and reference
standard(s)
Dementia, DSM-IV-TR
Flow and timing Information on timing is not clearly stated but we assume that the index test and reference standard
were conducted on the same day
Comparative -
Notes -
Upadhyaya 2010
Study characteristics
Patient sampling No information available
Patient characteristics and set-
ting
-
Index tests -
Target condition and reference
standard(s)
-
Flow and timing -
Comparative -
Notes -
Yu 2012
Study characteristics
Patient sampling “Three communities from ChaoYang District, 1 community from XiCheng District, and 2 villages
fromChang PingDistrict were then conveniently selected to recruit the participants from. Residents
listed in the census of the community registration that were aged 60 and above were contacted
for participation. 1056 participants participated in the present study, and 1001 participants were
included in the final data analyses based on the following inclusion and exclusion criteria. Inclusion
criteria were individuals (1) who were 60 years old or older and registered as permanent residents
in their residing district in Beijing (N = 1056), and (2) who completed both the MoCA-BJ and the
MMSE (N = 1036). Exclusion criteria were individuals (1) who had missing clinical diagnoses (N
= 25), and (2) who had received a clinical diagnosis of depression (N = 10).”
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Yu 2012 (Continued)
Patient characteristics and set-
ting
From table 1. Average age 70.66 years, average years of education 10.1 years, average MMSE 25.9.
57.1% female
Index tests MMSE
Target condition and reference
standard(s)
Dementia, DSM IV
Flow and timing -
Comparative -
Notes email sent 24 October to clarify missing information on sampling, case-control, flow and timing
DSM: Diagnostic and Statistical Manual of Mental Disorders; ICD: International Classification of Diseases; MMSE: Mini-Mental
State Examination.
Characteristics of ongoing studies [ordered by study ID]
Guiata 2012
Trial name or title InveCe.Ab study
Target condition and reference standard(s) Comparative
Index and comparator tests Comparative
Starting date Comparative
Contact information Antonio Guaita MD; GolgiCenci Foundation
Notes Prevalence study, no diagnostic test accuracy data published yet
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 MMSE at 14 normality 1 435
2 MMSE at 15 normality 2 935
3 MMSE at 16 normality 1 435
4 MMSE at 17 normality 4 1332
5 MMSE at 18 normality 9 3848
6 MMSE at 19 normality 9 4450
7 MMSE at 20 normality 9 4092
8 MMSE at 21 normality 8 4555
9 MMSE at 22 normality 9 4899
10 MMSE at 23 normality 11 4750
11MMSE at 24 normality (23/24) 25 12092
12 MMSE at 25 normality 16 6744
13 MMSE at 26 normality 9 5093
14 MMSE at 27 normality 6 4624
15 MMSE at 28 normality 3 2930
16 MMSE at 29 normality 2 691
17 MMSE at 30 normality 1 435
18 MMSE adjusted for education 8 8630
22 MMSE at 10 normality 1 500
23 Main analysis 27 13790
Test 1. MMSE at 14 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 1 MMSE at 14 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kahle-Wrobleski 2007 61 0 94 280 0.39 [ 0.32, 0.48 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. MMSE at 15 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 2 MMSE at 15 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kahle-Wrobleski 2007 66 0 89 280 0.43 [ 0.35, 0.51 ] 1.00 [ 0.99, 1.00 ]
Phantumchinda 1991 4 74 5 417 0.44 [ 0.14, 0.79 ] 0.85 [ 0.81, 0.88 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 3. MMSE at 16 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 3 MMSE at 16 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kahle-Wrobleski 2007 74 1 81 279 0.48 [ 0.40, 0.56 ] 1.00 [ 0.98, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 4. MMSE at 17 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 4 MMSE at 17 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Carnero-Pardo 2013 54 20 23 263 0.70 [ 0.59, 0.80 ] 0.93 [ 0.89, 0.96 ]
Kahle-Wrobleski 2007 82 2 73 278 0.53 [ 0.45, 0.61 ] 0.99 [ 0.97, 1.00 ]
Kathriarachchi 2005 5 2 9 21 0.36 [ 0.13, 0.65 ] 0.91 [ 0.72, 0.99 ]
Phantumchinda 1991 5 103 4 388 0.56 [ 0.21, 0.86 ] 0.79 [ 0.75, 0.83 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. MMSE at 18 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 5 MMSE at 18 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Carnero-Pardo 2013 62 23 15 260 0.81 [ 0.70, 0.89 ] 0.92 [ 0.88, 0.95 ]
Eefsting 1997 63 20 60 2008 0.51 [ 0.42, 0.60 ] 0.99 [ 0.98, 0.99 ]
Kahle-Wrobleski 2007 91 4 64 276 0.59 [ 0.51, 0.67 ] 0.99 [ 0.96, 1.00 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lindesay 1997 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 27 13 51 212 0.35 [ 0.24, 0.46 ] 0.94 [ 0.90, 0.97 ]
Phantumchinda 1991 7 123 2 368 0.78 [ 0.40, 0.97 ] 0.75 [ 0.71, 0.79 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
West Beijing Study 1989 10 32 0 57 1.00 [ 0.69, 1.00 ] 0.64 [ 0.53, 0.74 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 6. MMSE at 19 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 6 MMSE at 19 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Carnero-Pardo 2013 68 37 9 246 0.88 [ 0.79, 0.95 ] 0.87 [ 0.82, 0.91 ]
Cruz-Orduna 2012 12 20 3 125 0.80 [ 0.52, 0.96 ] 0.86 [ 0.80, 0.91 ]
Eefsting 1997 69 20 54 2008 0.56 [ 0.47, 0.65 ] 0.99 [ 0.98, 0.99 ]
Jeong 2004 42 45 4 144 0.91 [ 0.79, 0.98 ] 0.76 [ 0.69, 0.82 ]
Kahle-Wrobleski 2007 97 5 58 275 0.63 [ 0.54, 0.70 ] 0.98 [ 0.96, 0.99 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 35 22 43 203 0.45 [ 0.34, 0.57 ] 0.90 [ 0.86, 0.94 ]
Pandav 2002 32 192 11 571 0.74 [ 0.59, 0.86 ] 0.75 [ 0.72, 0.78 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 7. MMSE at 20 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 7 MMSE at 20 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Carnero-Pardo 2013 72 51 5 232 0.94 [ 0.85, 0.98 ] 0.82 [ 0.77, 0.86 ]
Eefsting 1997 74 41 49 1987 0.60 [ 0.51, 0.69 ] 0.98 [ 0.97, 0.99 ]
Kahle-Wrobleski 2007 105 9 50 271 0.68 [ 0.60, 0.75 ] 0.97 [ 0.94, 0.99 ]
Kathriarachchi 2005 7 4 7 19 0.50 [ 0.23, 0.77 ] 0.83 [ 0.61, 0.95 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lindesay 1997 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 45 33 33 192 0.58 [ 0.46, 0.69 ] 0.85 [ 0.80, 0.90 ]
Pandav 2002 35 304 8 459 0.81 [ 0.67, 0.92 ] 0.60 [ 0.57, 0.64 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 8. MMSE at 21 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 8 MMSE at 21 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Carnero-Pardo 2013 73 76 4 207 0.95 [ 0.87, 0.99 ] 0.73 [ 0.68, 0.78 ]
Eefsting 1997 80 61 43 1967 0.65 [ 0.56, 0.73 ] 0.97 [ 0.96, 0.98 ]
Kahle-Wrobleski 2007 114 13 41 267 0.74 [ 0.66, 0.80 ] 0.95 [ 0.92, 0.98 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 49 48 29 177 0.63 [ 0.51, 0.74 ] 0.79 [ 0.73, 0.84 ]
Pandav 2002 38 366 5 397 0.88 [ 0.75, 0.96 ] 0.52 [ 0.48, 0.56 ]
Phantumchinda 1991 8 196 1 295 0.89 [ 0.52, 1.00 ] 0.60 [ 0.56, 0.64 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 9. MMSE at 22 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 9 MMSE at 22 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Callahan 2002 13 31 2 298 0.87 [ 0.60, 0.98 ] 0.91 [ 0.87, 0.94 ]
Carnero-Pardo 2013 74 93 3 190 0.96 [ 0.89, 0.99 ] 0.67 [ 0.61, 0.73 ]
Eefsting 1997 85 101 38 1927 0.69 [ 0.60, 0.77 ] 0.95 [ 0.94, 0.96 ]
Kahle-Wrobleski 2007 124 19 31 261 0.80 [ 0.73, 0.86 ] 0.93 [ 0.90, 0.96 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 54 57 24 168 0.69 [ 0.58, 0.79 ] 0.75 [ 0.68, 0.80 ]
Pandav 2002 39 429 4 334 0.91 [ 0.78, 0.97 ] 0.44 [ 0.40, 0.47 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Phantumchinda 1991 9 231 0 260 1.00 [ 0.66, 1.00 ] 0.53 [ 0.48, 0.57 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 10. MMSE at 23 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 10 MMSE at 23 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Callahan 2002 13 36 2 293 0.87 [ 0.60, 0.98 ] 0.89 [ 0.85, 0.92 ]
Carnero-Pardo 2013 76 122 1 161 0.99 [ 0.93, 1.00 ] 0.57 [ 0.51, 0.63 ]
Eefsting 1997 89 122 34 1906 0.72 [ 0.64, 0.80 ] 0.94 [ 0.93, 0.95 ]
Kahle-Wrobleski 2007 130 27 25 253 0.84 [ 0.77, 0.89 ] 0.90 [ 0.86, 0.94 ]
Kathriarachchi 2005 9 8 5 15 0.64 [ 0.35, 0.87 ] 0.65 [ 0.43, 0.84 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lavery 2007 19 23 9 263 0.68 [ 0.48, 0.84 ] 0.92 [ 0.88, 0.95 ]
Lindesay 1997 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 59 65 19 160 0.76 [ 0.65, 0.85 ] 0.71 [ 0.65, 0.77 ]
Pandav 2002 39 494 4 269 0.91 [ 0.78, 0.97 ] 0.35 [ 0.32, 0.39 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 11. MMSE at 24 normality (23/24).
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 11 MMSE at 24 normality (23/24)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
ADAMS Study 2007 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Aevarsson 2000 97 14 20 297 0.83 [ 0.75, 0.89 ] 0.95 [ 0.93, 0.98 ]
Baker 1993 1 9 0 45 1.00 [ 0.03, 1.00 ] 0.83 [ 0.71, 0.92 ]
Burkart 2000 20 2 3 231 0.87 [ 0.66, 0.97 ] 0.99 [ 0.97, 1.00 ]
Callahan 2002 14 44 1 285 0.93 [ 0.68, 1.00 ] 0.87 [ 0.82, 0.90 ]
Carnero-Pardo 2013 77 153 0 130 1.00 [ 0.95, 1.00 ] 0.46 [ 0.40, 0.52 ]
Eefsting 1997 93 183 30 1845 0.76 [ 0.67, 0.83 ] 0.91 [ 0.90, 0.92 ]
Fillenbaum 1990 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Frank 1996 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Helsinki Aging Study 1994 57 0 36 0 0.61 [ 0.51, 0.71 ] 0.0 [ 0.0, 0.0 ]
Heun 1998 31 3 6 248 0.84 [ 0.68, 0.94 ] 0.99 [ 0.97, 1.00 ]
Kahle-Wrobleski 2007 132 54 23 226 0.85 [ 0.79, 0.90 ] 0.81 [ 0.76, 0.85 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Kungsholmen Study 1992 305 98 9 256 0.97 [ 0.95, 0.99 ] 0.72 [ 0.67, 0.77 ]
Lourenco 2006 63 78 15 147 0.81 [ 0.70, 0.89 ] 0.65 [ 0.59, 0.72 ]
Mackinnon 2003 17 31 19 580 0.47 [ 0.30, 0.65 ] 0.95 [ 0.93, 0.97 ]
Maki 2000 44 61 5 552 0.90 [ 0.78, 0.97 ] 0.90 [ 0.87, 0.92 ]
MoVies Study 1993 54 63 22 980 0.71 [ 0.60, 0.81 ] 0.94 [ 0.92, 0.95 ]
Pandav 2002 39 536 4 227 0.91 [ 0.78, 0.97 ] 0.30 [ 0.27, 0.33 ]
PAQUID Study 64 612 0 2051 1.00 [ 0.94, 1.00 ] 0.77 [ 0.75, 0.79 ]
Pond 1994 21 16 36 295 0.37 [ 0.24, 0.51 ] 0.95 [ 0.92, 0.97 ]
Ramlall 2013 7 31 4 98 0.64 [ 0.31, 0.89 ] 0.76 [ 0.68, 0.83 ]
Rummans 1996 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Schultz-Larsen 2007 25 3 44 170 0.36 [ 0.25, 0.49 ] 0.98 [ 0.95, 1.00 ]
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Test 12. MMSE at 25 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 12 MMSE at 25 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
AMSTEL Study 1997 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Brodaty 2002 66 23 16 71 0.80 [ 0.70, 0.88 ] 0.76 [ 0.66, 0.84 ]
Burkart 2000 21 7 2 226 0.91 [ 0.72, 0.99 ] 0.97 [ 0.94, 0.99 ]
Callahan 2002 15 53 0 276 1.00 [ 0.78, 1.00 ] 0.84 [ 0.79, 0.88 ]
Carnero-Pardo 2013 77 175 0 108 1.00 [ 0.95, 1.00 ] 0.38 [ 0.32, 0.44 ]
Eefsting 1997 98 264 25 1764 0.80 [ 0.71, 0.86 ] 0.87 [ 0.85, 0.88 ]
Heun 1998 34 10 3 240 0.92 [ 0.78, 0.98 ] 0.96 [ 0.93, 0.98 ]
Kahle-Wrobleski 2007 141 76 14 204 0.91 [ 0.85, 0.95 ] 0.73 [ 0.67, 0.78 ]
Keskinoglu 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Lourenco 2006 67 92 11 133 0.86 [ 0.76, 0.93 ] 0.59 [ 0.52, 0.66 ]
MoVies Study 1993 60 126 16 917 0.79 [ 0.68, 0.87 ] 0.88 [ 0.86, 0.90 ]
Pandav 2002 39 567 4 196 0.91 [ 0.78, 0.97 ] 0.26 [ 0.23, 0.29 ]
Ramlall 2013 115 4 25 7 0.82 [ 0.75, 0.88 ] 0.64 [ 0.31, 0.89 ]
Scazufca 2009 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Schultz-Larsen 2007 36 7 33 166 0.52 [ 0.40, 0.64 ] 0.96 [ 0.92, 0.98 ]
Winblad 2010 24 58 0 32 1.00 [ 0.86, 1.00 ] 0.36 [ 0.26, 0.46 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 13. MMSE at 26 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 13 MMSE at 26 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Callahan 2002 15 82 0 247 1.00 [ 0.78, 1.00 ] 0.75 [ 0.70, 0.80 ]
Eefsting 1997 103 406 20 1622 0.84 [ 0.76, 0.90 ] 0.80 [ 0.78, 0.82 ]
Heun 1998 36 23 1 228 0.97 [ 0.86, 1.00 ] 0.91 [ 0.87, 0.94 ]
Kahle-Wrobleski 2007 146 102 9 178 0.94 [ 0.89, 0.97 ] 0.64 [ 0.58, 0.69 ]
Lourenco 2006 70 113 8 112 0.90 [ 0.81, 0.95 ] 0.50 [ 0.43, 0.56 ]
Macedo Montano 2005 34 74 0 48 1.00 [ 0.90, 1.00 ] 0.39 [ 0.31, 0.49 ]
Pandav 2002 39 593 4 170 0.91 [ 0.78, 0.97 ] 0.22 [ 0.19, 0.25 ]
Pond 1994 38 28 19 283 0.67 [ 0.53, 0.79 ] 0.91 [ 0.87, 0.94 ]
Schultz-Larsen 2007 50 15 19 158 0.72 [ 0.60, 0.83 ] 0.91 [ 0.86, 0.95 ]
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Test 14. MMSE at 27 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 14 MMSE at 27 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Callahan 2002 15 123 0 206 1.00 [ 0.78, 1.00 ] 0.63 [ 0.57, 0.68 ]
Eefsting 1997 108 588 15 1440 0.88 [ 0.81, 0.93 ] 0.71 [ 0.69, 0.73 ]
Kahle-Wrobleski 2007 150 149 5 131 0.97 [ 0.93, 0.99 ] 0.47 [ 0.41, 0.53 ]
Mackinnon 2003 27 110 9 500 0.75 [ 0.58, 0.88 ] 0.82 [ 0.79, 0.85 ]
Pandav 2002 40 624 3 139 0.93 [ 0.81, 0.99 ] 0.18 [ 0.16, 0.21 ]
Schultz-Larsen 2007 54 26 15 147 0.78 [ 0.67, 0.87 ] 0.85 [ 0.79, 0.90 ]
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Test 15. MMSE at 28 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 15 MMSE at 28 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Callahan 2002 15 179 0 150 1.00 [ 0.78, 1.00 ] 0.46 [ 0.40, 0.51 ]
Eefsting 1997 113 913 10 1115 0.92 [ 0.86, 0.96 ] 0.55 [ 0.53, 0.57 ]
Kahle-Wrobleski 2007 152 201 3 79 0.98 [ 0.94, 1.00 ] 0.28 [ 0.23, 0.34 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 16. MMSE at 29 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 16 MMSE at 29 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Burkart 2000 22 142 1 91 0.96 [ 0.78, 1.00 ] 0.39 [ 0.33, 0.46 ]
Kahle-Wrobleski 2007 154 251 1 29 0.99 [ 0.96, 1.00 ] 0.10 [ 0.07, 0.15 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 17. MMSE at 30 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 17 MMSE at 30 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Kahle-Wrobleski 2007 155 280 0 0 1.00 [ 0.98, 1.00 ] 0.0 [ 0.0, 0.01 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 18. MMSE adjusted for education.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 18 MMSE adjusted for education
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Correira 2001 15 44 0 50 1.00 [ 0.78, 1.00 ] 0.53 [ 0.43, 0.64 ]
Iavarone 2006 66 78 9 141 0.88 [ 0.78, 0.94 ] 0.64 [ 0.58, 0.71 ]
Jacinto 2011 11 7 6 34 0.65 [ 0.38, 0.86 ] 0.83 [ 0.68, 0.93 ]
Lam 2008 143 1614 0 4343 1.00 [ 0.97, 1.00 ] 0.73 [ 0.72, 0.74 ]
Liu 1996a 45 86 0 44 1.00 [ 0.92, 1.00 ] 0.34 [ 0.26, 0.43 ]
Mingyuan 1998 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Rosselli 2000 12 315 1 365 0.92 [ 0.64, 1.00 ] 0.54 [ 0.50, 0.57 ]
Tang 1999 26 51 3 1121 0.90 [ 0.73, 0.98 ] 0.96 [ 0.94, 0.97 ]
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Test 22. MMSE at 10 normality.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 22 MMSE at 10 normality
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Phantumchinda 1991 1 25 8 466 0.11 [ 0.00, 0.48 ] 0.95 [ 0.93, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 23. Main analysis.
Review: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care
populations
Test: 23 Main analysis
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aevarsson 2000 97 14 20 297 0.83 [ 0.75, 0.89 ] 0.95 [ 0.93, 0.98 ]
Baker 1993 1 9 0 45 1.00 [ 0.03, 1.00 ] 0.83 [ 0.71, 0.92 ]
Brodaty 2002 66 23 16 71 0.80 [ 0.70, 0.88 ] 0.76 [ 0.66, 0.84 ]
Burkart 2000 20 2 3 231 0.87 [ 0.66, 0.97 ] 0.99 [ 0.97, 1.00 ]
Callahan 2002 14 44 1 285 0.93 [ 0.68, 1.00 ] 0.87 [ 0.82, 0.90 ]
Carnero-Pardo 2013 77 153 0 130 1.00 [ 0.95, 1.00 ] 0.46 [ 0.40, 0.52 ]
Cruz-Orduna 2012 12 20 3 125 0.80 [ 0.52, 0.96 ] 0.86 [ 0.80, 0.91 ]
Eefsting 1997 93 183 30 1845 0.76 [ 0.67, 0.83 ] 0.91 [ 0.90, 0.92 ]
Heun 1998 31 3 6 248 0.84 [ 0.68, 0.94 ] 0.99 [ 0.97, 1.00 ]
Jeong 2004 42 45 4 144 0.91 [ 0.79, 0.98 ] 0.76 [ 0.69, 0.82 ]
Kahle-Wrobleski 2007 132 54 23 226 0.85 [ 0.79, 0.90 ] 0.81 [ 0.76, 0.85 ]
Kathriarachchi 2005 9 8 5 15 0.64 [ 0.35, 0.87 ] 0.65 [ 0.43, 0.84 ]
Kungsholmen Study 1992 305 98 9 256 0.97 [ 0.95, 0.99 ] 0.72 [ 0.67, 0.77 ]
Lavery 2007 19 23 9 263 0.68 [ 0.48, 0.84 ] 0.92 [ 0.88, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Lourenco 2006 63 78 15 147 0.81 [ 0.70, 0.89 ] 0.65 [ 0.59, 0.72 ]
Macedo Montano 2005 34 74 0 48 1.00 [ 0.90, 1.00 ] 0.39 [ 0.31, 0.49 ]
Mackinnon 2003 17 31 19 580 0.47 [ 0.30, 0.65 ] 0.95 [ 0.93, 0.97 ]
Maki 2000 44 61 5 552 0.90 [ 0.78, 0.97 ] 0.90 [ 0.87, 0.92 ]
MoVies Study 1993 54 63 22 980 0.71 [ 0.60, 0.81 ] 0.94 [ 0.92, 0.95 ]
Pandav 2002 39 536 4 227 0.91 [ 0.78, 0.97 ] 0.30 [ 0.27, 0.33 ]
PAQUID Study 64 612 0 2051 1.00 [ 0.94, 1.00 ] 0.77 [ 0.75, 0.79 ]
Phantumchinda 1991 7 123 2 368 0.78 [ 0.40, 0.97 ] 0.75 [ 0.71, 0.79 ]
Pond 1994 21 16 36 295 0.37 [ 0.24, 0.51 ] 0.95 [ 0.92, 0.97 ]
Ramlall 2013 7 31 4 98 0.64 [ 0.31, 0.89 ] 0.76 [ 0.68, 0.83 ]
Schultz-Larsen 2007 25 3 44 170 0.36 [ 0.25, 0.49 ] 0.98 [ 0.95, 1.00 ]
West Beijing Study 1989 10 32 0 57 1.00 [ 0.69, 1.00 ] 0.64 [ 0.53, 0.74 ]
Winblad 2010 24 58 0 32 1.00 [ 0.86, 1.00 ] 0.36 [ 0.26, 0.46 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. Summary of included community studies
Study Number of cita-
tionsa
Sample size Number of peo-
ple with demen-
tia
Prevalence of de-
mentia
Reference stan-
dard
Reported
MMSE
cut points indi-
cating normal
Studies where 2 x 2 data was available
Aevarsson 2000 1 428 117 27.3% DSM-III 24
Baker 1993 1 55 1 1.8% DSM-III-R 24
Burkart 2000 1 256 23 9.0% DSM-III-R 24, 25, 29
Callahan 2002 1 344 15 4.6% DSM-III-R 22, 23, 24, 25,
26, 27, 28
Correira 2001 1 109 15 13.8% DSM-IV Adjusted for edu-
cation
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Table 1. Summary of included community studies (Continued)
Eefsting 1997 1 2151 123 5.7% DSM-III-R 18, 19, 20, 21,
22, 23, 24, 25,
26, 27, 28
Heun 1998 1 287 37 12.9% DSM-III-R 24, 25, 26
Iavarone 2006 1 294 75 25.5% DSM-IV Adjusted for edu-
cation
Jacinto 2011 1 58 17 29.3% DSM-IV Adjusted for edu-
cation
Jeong 2004 1 235 46 19.6% DSM-IV 19
Kahle-Wrobleski
2007
1 435 157 36.0% DSM-IV 14, 15, 16, 17,
18, 19, 20, 21,
22, 23, 24, 25,
26, 27, 28, 29, 30
Kathriarachchi
2005
1 37 17 38.0% CDR 17, 20, 23
Kungsholmen
Study 1992
7 668 314 47.0% DSM-III-R 24
Macedo
Montano 2005
1 156 34 21.8% DSM-IV-R 26
Mackinnon
2003
1 646 36 5.6% DSM-III-R 24, 27
Maki 2000 1 662 49 7.4% DSM-III-R 24
MoVies Study
1993
5 1119 76 6.8% DSM-III-R 24, 25
Lam 2008 1 5957 143 2.4% DSM-IV Adjusted for edu-
cation
Liu 1996a 1 130 45 34.6% DSM-III Adjusted for edu-
cation
Pandav 2002 1 806 43 5.3% DSM-III-R 19, 20, 21, 22,
23, 24, 25, 26, 27
PAQUID Study 5 2730 101 3.7% DSM-III 24
Phantumchinda
1991
1 500 9 1.8% DSM-III 10, 15, 17, 18,
21, 22
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Table 1. Summary of included community studies (Continued)
Ramlall 2013 1 140 11 7.9% DSM-IV-R 24, 25
Rosselli 2000 1 693 13 1.9% DSM-IV Adjusted for edu-
cation
Schultz-Larsen
2007
1 242 69 28.5% DSM-IV 24, 25, 26, 27
Tang 1999 1 1201 29 2.4% DSM-III-R Adjusted for edu-
cation
West Beijing
Study 1989.
2 99 10 10.1 DSM-III 18
Winblad 2010 1 114 24 21.1% DSM-IV 25
Studies where 2 x 2 data was not available
ADAMS Study
2007
3 509 129 25.3% DSM-IV -
AMSTEL Study
1997
4 4123 261 6.3% DSM-III-R -
Fichter 1995 1 402 85 21.2% DSM-III-R -
Fillenbaum
1990
1 4164 26 0.6% DSM-III-R -
Frank 1996 1 380 56 14.7% NINCDS-
ADRDA
-
Helsinki Aging
Study 1994b
2 656 93 14.2% DSM-III-R -
Keskinoglu
2009
1 490 63 12.9% DSM-III -
Lee 2002 1 643 40 6.2% DSM-III -
Li 2006 1 144 19 13.1% DSM-III -
Lindesay 1997 1 297 Not reported Not reported DSM-III -
Mingyuan 1998 1 Not reported Not reported Not reported DSM-III-R -
Rummans 1996 1 201 21 10.4% DSM-III-R -
Scazufca 2009 1 1933 84 4.3% DSM-IV -
165Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community
and primary care populations (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Summary of included community studies (Continued)
Wilder 1995 1 795 Not reported - DSM-III -
CDR: clinical dementia rating; DSM: Diagnostic and Statistical Manual of Mental Disorders; NINCDS-ADRDA: National Institute
of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association.
aRefers to the number of citations that we retrieved that refer to the same study and are listed in Included studies.
bStudy reported sensitivity only and so could not be included in meta-analysis in absence of paired data.
Table 2. Summary of included primary care studies
Study Number of cita-
tionsa
Sample size Number of peo-
ple with demen-
tia
Prevalence of de-
mentia
Reference stan-
dard
ReportedMMSE
cut points indi-
cating normal
Setting: asymptomatic primary care
Brodaty 2002 1 176 82 46.6% DSM-IV 25
Lavery 2007 1 313 28 8.9% CDR 23
Lourenco 2006 1 303 78 25.7% DSM-IV 18, 19, 20, 21, 22,
23, 24, 25, 26
Pond 1994 1 367 57 15.5% DSM-III-R 24, 26
Setting: symptomatic primary care
Carnero-Pardo
2013
3 360 77 21.4% DSM-IV-R 17, 18, 19, 20, 21,
22, 23, 24, 25
Cruz-Orduna
2012
1 160 15 9.4% DSM-IV-R 19
CDR: clinical dementia rating; DSM: Diagnostic and Statistical Manual of Mental Disorders.
aRefers to the number of citations that we retrieved that refer to the same study and are listed in Included studies.
Table 3. Papers included in Mitchell 2009 review but not in this review
Citation Setting and
sample
Prevalence
of dementia
Index Test Cut
point indi-
cating nor-
mal
Reference
Standard
Sensitivity Specificity Reason for ex-
clusion from
this review
Belle 2000 MoVies
Study 1993
Community
age-strati-
68 dementia
and 1110 no
dementia
MMSE 27 Short and
Sweet
Screening
96% 78% No mention of
MMSE
in abstract and
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Table 3. Papers included in Mitchell 2009 review but not in this review (Continued)
fied random
sample
Instrument wrong refer-
ence standard
in this paper
but data from
study (from
another paper)
included in our
review
Brayne 1989 Community
Strati-
fied random
sam-
ple of 365
women aged
70-79 years
29 dementia
336 no de-
mentia
MMSE 22 CAMDEX 83% 87% No mention of
MMSE
in abstract and
wrong refer-
ence standard
Clarke 1991 Community
Total sample
of all people
aged over 75
years on 1
GP list
265 demen-
tia, 150 no
dementia
MMSE 22 CAMDEX 77% 71% Wrong refer-
ence standard
Cullen 2005 Community
Sam-
ple of people
aged over 65
years from
GP lists
44 dementia
1071 no de-
mentia
MMSE 24 AGECAT 91% 87% Wrong refer-
ence standard
Hooijer
1992
AMSTEL
Study 1997
All elderly
patients of 1
Amsterdam
GP
13 dementia
345 no de-
mentia
MMSE 24 CAMDEX 77% 97% Wrong refer-
ence standard
in this paper
but data from
study (from
another paper)
included in our
review
O’Connor
1989
Community
Total sample
of all people
aged over 75
on 5 GP lists
196 demen-
tia 285 no
dementia
MMSE 24 CAMDEX 86% 92% Wrong refer-
ence standard
Wind 1997 AMSTEL
Study 1997
Age strati-
fied sam-
114 demen-
tia 419 no
dementia
MMSE 24 AGECAT 69% 89% Wrong refer-
ence standard
in this paper
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Table 3. Papers included in Mitchell 2009 review but not in this review (Continued)
ple of partic-
ipating prac-
tices in AM-
STEL
but data from
study (from
another paper)
included in our
review
Huppert
2005
Community
MRC-
CFAS study
Random,
age-strati-
fied sam-
pling of peo-
ple aged over
65 years
795 demen-
tia 11,885
no dementia
MMSE 23 AGECAT 88% 92% Wrong refer-
ence standard,
abstract makes
no mention of
diagnostic ac-
curacy and di-
agnostic accu-
racy terms such
as sensitivity
and specificity
do not appear
in the paper
A P P E N D I C E S
Appendix 1. Classification of dementia
World Health Organization International Classification of Diseases-10
G1. Evidence of each of the following:
• A decline in memory, which is most evident in the learning of new information, although in more severe cases, the recall of
previously learned information also may be affected. The impairment applies to both verbal and nonverbal material. The decline
should be objectively verified by obtaining a reliable history from an informant, supplemented, if possible, by neuropsychological tests
or quantified cognitive assessments.
• A decline in other cognitive abilities characterised by deterioration in judgement and thinking, such as planning and organising,
and in the general processing of information. Evidence for this should be obtained when possible by interviewing an informant,
supplemented, if possible, by neuropsychological tests or quantified objective assessments. Deterioration from a previously higher
level of performance should be established.
G2. Preserved awareness of the environment during a period long enough to enable the unequivocal demonstration of G1. When
episodes of delirium are superimposed, the diagnosis of dementia should be deferred.
G3. A decline in emotional control or motivation, or a change in social behaviour, manifest as at least one of the following.
• Emotional liability.
• Irritability.
• Apathy.
• Coarsening of social behaviour.
G4. For a confident clinical diagnosis, G1 should have been present for at least six months; if the period since the manifest onset is
shorter, the diagnosis can only be tentative.
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision
A. The development of multiple cognitive deficits manifested by both:
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1. memory impairment (impaired ability to learn new information or to recall previously learned information;
2. one (or more) of the following cognitive disturbances.
◦ Aphasia (language disturbance).
◦ Apraxia (impaired ability to carry out motor activities despite intact motor function).
◦ Agnosia (failure to recognise or identify objects despite intact sensory function).
◦ Disturbance in executive functioning (i.e. planning, organizing, sequencing, abstracting).
B. Each of the cognitive deficits in Criteria A1 and A2
• Causes significant impairment in social or occupational functioning.
• Represents a significant decline from a previous level of functioning.
C. The deficits do not occur exclusively during the course of a delirium.
D. The disturbance is not better accounted for by another Axis I disorder (e.g. major depressive disorder, schizophrenia).
Appendix 2. Sources searched and search strategies
Source Search strategy Hits retrieved
1. MEDLINE In-process and other non-
indexed citations and MEDLINE 1950-
present (Ovid SP)
Most recent search: 20 May 2014
1. MMSE*.ti,ab.
2. sMMSE.ti,ab.
3. Folstein*.ti,ab.
4. MiniMental.ti,ab.
5. “mini mental stat*”.ti,ab.
6. or/1-5
Nov 2012: 10048
May 2014: 1657
2. EMBASE
1980-2012 November 16 (Ovid SP)
Most recent search: 20 May 2014
1. MMSE*.ti,ab.
2. sMMSE.ti,ab.
3. Folstein*.ti,ab.
4. MiniMental.ti,ab.
5. “mini mental stat*”.ti,ab.
6. 3MS.ti,ab.
7. *mini mental state examination/
8. or/1-7
9. dement*.ti,ab.
10. alzheimer*.ti,ab.
11. exp *dementia/
12. “vascular cognitive impair*”.ti,ab.
13. (“lewy bod*” or DLB or LBD).ti,ab.
14. (AD or VaD or FTLD or FTD or DLB
or LDB).ti,ab.
15. delirium/
16. deliri*.ti,ab.
17. or/9-16
18. exp *mild cognitive impairment/
19. “cognit* impair*”.ti,ab.
20. (forgetful* or confused or confusion).
ti,ab.
21. MCI.ti,ab.
22. ACMI.ti,ab.
Nov 2012: 11675
May 2014: 2774
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(Continued)
23. ARCD.ti,ab.
24. SMC.ti,ab.
25. CIND.ti,ab.
26. BSF.ti,ab.
27. AAMI.ti,ab.
28. LCD.ti,ab.
29. QD.ti,ab.
30. AACD.ti,ab.
31. MNCD.ti,ab.
32. MCD.ti,ab.
33. (nMCI or aMCI or mMCI).ti,ab.
34. (“N-MCI” or “A-MCI” or “M-MCI”)
.ti,ab.
35. “Petersen criteria”.ab.
36. ((CDR adj2 “0.5”) or (“clinical demen-
tia rating” adj3 “0.5”)).ab
37. “cognit* declin*”.ti,ab.
38. “cognit* deficit*”.ti,ab.
39. or/18-38
40. 17 or 39
41. 8 and 40
3. PsycINFO
1806-November week 2 2012 (Ovid SP)
Most recent search: 20 May 2014
1. exp Dementia/
2. exp Delirium/
3. exp Huntingtons Disease/
4. exp Kluver Bucy Syndrome/
5. exp Wernickes Syndrome/
6. exp Cognitive Impairment/
7. dement*.mp.
8. alzheimer*.mp.
9. (lewy* adj2 bod*).mp.
10. deliri*.mp.
11. (chronic adj2 cerebrovascular).mp.
12. (“organic brain disease” or “organic
brain syndrome”).mp
13. “supranuclear palsy”.mp.
14. (“normal pressure hydrocephalus” and
“shunt*”).mp.
15. “benign senescent forgetfulness”.mp.
16. (cerebr* adj2 deteriorat*).mp.
17. (cerebral* adj2 insufficient*).mp.
18. (pick* adj2 disease).mp.
19. (creutzfeldt or jcd or cjd).mp.
20. huntington*.mp.
21. binswanger*.mp.
22. korsako*.mp.
23. (“parkinson* disease dementia” or PDD
or “parkinson* dementia”).mp
24. or/1-23
Nov 2012: 5740
May 2014: 728
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25. “cognit* impair*”.mp.
26. exp Cognitive Impairment/
27. MCI.ti,ab.
28. ACMI.ti,ab.
29. ARCD.ti,ab.
30. SMC.ti,ab.
31. CIND.ti,ab.
32. BSF.ti,ab.
33. AAMI.ti,ab.
34. MD.ti,ab.
35. LCD.ti,ab.
36. QD.ti,ab.
37. AACD.ti,ab.
38. MNCD.ti,ab.
39. MCD.ti,ab.
40. (“N-MCI” or “A-MCI” or “M-MCI”)
.ti,ab.
41. ((cognit* ormemory or cerebr* ormen-
tal*) adj3 (declin* or impair* or los* or de-
teriorat* or degenerat* or complain* or dis-
turb* or disorder*)).ti,ab
42. “preclinical AD”.mp.
43. “pre-clinical AD”.mp.
44. (“preclinical alzheimer*” or “pre-clini-
cal alzheimer*”).mp
45. (aMCI or MCIa).ti,ab.
46. (“CDR 0.5” or “clinical dementia rat-
ing scale 0.5”).ti,ab
47. (“GDS 3” or “stage 3 GDS”).ti,ab.
48. (“global deterioration scale” and “stage
3”).mp.
49. “Benign senescent forgetfulness”.ti,ab.
50. “mild neurocognit* disorder*”.ti,ab.
51. (prodrom* adj2 dement*).ti,ab.
52. “age-related symptom*”.mp.
53. (episodic adj2 memory).mp.
54. (“pre-clinical dementia” or “preclinical
dementia”).mp.
55. or/25-54
56. 24 or 55
57. mini mental state examination/
58. “mini mental stat*”.ti,ab.
59. MiniMental.ti,ab.
60. Folstein*.ti,ab.
61. sMMSE.ti,ab.
62. MMSE*.ti,ab.
63. or/57-62
64. 56 and 63
171Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community
and primary care populations (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
4. Biosis previews 1926 to present (Thom-
son Reuters Web of Science)
Most recent search: 20 May 2014
Topic=(MMSE OR sMMSE OR “mini
mental stat*” OR folstein* OR MiniMen-
tal) ANDTopic=(detect* ORdiagnos* OR
predict* OR identify OR validity OR vali-
dation OR validate ORutility OR sensitiv-
ity OR specificity OR screen* OR preval*
OR incidence) AND Topic=(dement* OR
alzheimer* OR cognitive OR cognition
OR memory OR MCI OR petersen)
Timespan=All Years. Databases=BIOSIS
Previews.
Lemmatization=On
Nov 2012: 5713
May 2014: 609
5. Web of Science Core Collection, in-
cluding the Science Citation Index and
theConference ProceedingsCitation Index
(Thomson Reuters Web of Science)
Most recent search: 20 May 2014
Topic=(MMSE OR sMMSE OR “mini
mental stat*” OR folstein* OR MiniMen-
tal) ANDTopic=(detect* ORdiagnos* OR
predict* OR identify OR validity OR vali-
dation OR validate ORutility OR sensitiv-
ity OR specificity OR screen* OR preval*
OR incidence) AND Topic=(dement* OR
alzheimer* OR cognitive OR cognition
OR memory OR MCI OR petersen)
Timespan=1975-
01-01 - 2012-11-20. Databases=SCI-EX-
PANDED, SSCI, CPCI-S, CPCI-SSH
Lemmatization=On
Nov 2012: 7337
May 2014: 992
6. LILACS (BIREME)
Most recent search: 20 May 2014
MMSE OR folstein OR “mini men-
tal stat$” OR sMMSE OR MiniMental
[Words]
Nov 2012: 224
May 2014: 28
7. ALOIS (CDCIG specialized register
searched via theCochrane Register of Stud-
ies)
Most recent search: 20 May 2014
Index test field: MMSE
The Dementia group register is based on a
regular search ofMEDLINE for diagnostic
test accuracy studies using the strategy be-
low. Relevant citations identified are then
looked at in full and the healthcare con-
dition of interest and index test/s are ex-
tracted and entered into the register
1. “word recall”.ti,ab.
2. (“7-minute screen” OR “seven-minute
screen”).ti,ab.
3. (“6 item cognitive impairment test” OR
“six-item cognitive impairment test”).ti,ab
4. “6 CIT”.ti,ab.
5. “AB cognitive screen”.ti,ab.
6. “abbreviated mental test”.ti,ab.
7. “ADAS-cog”.ti,ab.
8. AD8.ti,ab.
Nov 2012: 251
May 2014: 31
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9. “inform* interview”.ti,ab.
10. “animal fluency test”.ti,ab.
11. “brief alzheimer* screen”.ti,ab.
12. “brief cognitive scale”.ti,ab.
13. “clinical dementia rating scale”.ti,ab.
14. “clinical dementia test”.ti,ab.
15. “community screening interview for
dementia”.ti,ab.
16. “cognitive abilities screening instru-
ment”.ti,ab.
17. “cognitive assessment screening test”.
ti,ab.
18. “cognitive capacity screening examina-
tion”.ti,ab.
19. “clock drawing test”.ti,ab.
20. “deterioration cognitive observee”.ti,
ab.
21. (“Dem Tect” OR DemTect).ti,ab.
22. “object memory evaluation”.ti,ab.
23. “IQCODE”.ti,ab.
24. “mattis dementia rating scale”.ti,ab.
25. “memory impairment screen”.ti,ab.
26. “minnesota cognitive acuity screen”.ti,
ab.
27. “mini-cog”.ti,ab.
28. “mini-mental state exam*”.ti,ab.
29. “mmse”.ti,ab.
30. “modified mini-mental state exam”.ti,
ab.
31. “3MS”.ti,ab.
32. “neurobehavio?ral cognitive status
exam*”.ti,ab.
33. “cognistat”.ti,ab.
34. “quick cognitive screening test”.ti,ab.
35. “QCST”.ti,ab.
36. “rapid dementia screening test”.ti,ab.
37. “RDST”.ti,ab.
38. “repeatable battery for the assessment
of neuropsychological status”.ti,ab
39. “RBANS”.ti,ab.
40. “rowland universal dementia assess-
ment scale”.ti,ab.
41. “rudas”.ti,ab.
42. “self-administered gerocognitive
exam*”.ti,ab.
43. (“self-administered” and “SAGE”).ti,
ab
44. “self-administered computerized
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screening test for dementia”.ti,ab
45. “short and sweet screening instru-
ment”.ti,ab.
46. “sassi”.ti,ab.
47. “short cognitive performance test”.ti,
ab.
48. “syndrome kurztest”.ti,ab.
49. (“six item screener” OR “6-item
screener”).ti,ab.
50. “short memory questionnaire”.ti,ab.
51. (“short memory questionnaire” and
“SMQ”).ti,ab.
52. “short orientation memory concentra-
tion test”.ti,ab.
53. “s-omc”.ti,ab.
54. “short blessed test”.ti,ab.
55. “short portable mental status question-
naire”.ti,ab.
56. “spmsq”.ti,ab.
57. “short test of mental status”.ti,ab.
58. “telephone interview of cognitive status
modified”.ti,ab
59. “tics-m”.ti,ab.
60. “trail making test”.ti,ab.
61. “verbal fluency categories”.ti,ab.
62. “WORLD test”.ti,ab.
63. “general practitioner assessment of cog-
nition”.ti,ab.
64. “GPCOG”.ti,ab.
65. “Hopkins verbal learning test”.ti,ab.
66. “HVLT”.ti,ab.
67. “time and change test”.ti,ab.
68. “modified world test”.ti,ab.
69. “symptoms of dementia screener”.ti,ab.
70. “dementia questionnaire”.ti,ab.
71. “7MS”.ti,ab.
72. (“concord informant dementia scale”
or CIDS).ti,ab.
73. (SAPHor “dementia screening and per-
ceived harm*”).ti,ab
74. or/1-73
75. exp Dementia/
76. Delirium, Dementia, Amnestic, Cog-
nitive Disorders/
77. dement*.ti,ab.
78. alzheimer*.ti,ab.
79. AD.ti,ab.
80. (“lewy bod*” or DLB or LBD or FTD
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or FTLD or “frontotemporal lobar degen-
eration” or “frontaltemporal dement*).ti,ab
81. “cognit* impair*”.ti,ab.
82. (cognit* adj4 (disorder* or declin* or
fail* or function* or degenerat* or deterio-
rat*)).ti,ab
83. (memory adj3 (complain* or declin* or
function* or disorder*)).ti,ab
84. or/75-83
85. exp “sensitivity and specificity”/
86. “reproducibility of results”/
87. (predict* adj3 (dement* or AD or
alzheimer*)).ti,ab.
88. (identif* adj3 (dement* or AD or
alzheimer*)).ti,ab.
89. (discriminat* adj3 (dement* or AD or
alzheimer*)).ti,ab.
90. (distinguish* adj3 (dement* or AD or
alzheimer*)).ti,ab.
91. (differenti* adj3 (dement* or AD or
alzheimer*)).ti,ab.
92. diagnos*.ti.
93. di.fs.
94. sensitivit*.ab.
95. specificit*.ab.
96. (ROC or “receiver operat*”).ab.
97. Area under curve/
98. (“Area under curve” or AUC).ab.
99. (detect* adj3 (dement* or AD or
alzheimer*)).ti,ab.
100. sROC.ab.
101. accura*.ti,ab.
102. (likelihood adj3 (ratio* or function*)
).ab.
103. (conver* adj3 (dement* or AD or
alzheimer*)).ti,ab.
104. ((true or false) adj3 (positive* or neg-
ative*)).ab.
105. ((positive* or negative* or false or true)
adj3 rate*).ti,ab
106. or/85-105
107. exp dementia/di
108. Cognition Disorders/di [Diagnosis]
109. Memory Disorders/di
110. or/107-109
111. *Neuropsychological Tests/
112. *Questionnaires/
113. Geriatric Assessment/mt
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114. *Geriatric Assessment/
115. Neuropsychological Tests/mt, st
116. “neuropsychological test*”.ti,ab.
117. (neuropsychological adj (assess* or
evaluat* or test*)).ti,ab
118. (neuropsychological adj (assess* or
evaluat* or test* or exam* or battery)).ti,ab
119. Self report/
120. self-assessment/ or diagnostic self eval-
uation/
121. Mass Screening/
122. early diagnosis/
123. or/111-122
124. 74 or 123
125. 110 and 124
126. 74 or 123
127. 84 and 106 and 126
128. 74 and 106
129. 125 or 127 or 128
130. exp Animals/ not Humans.sh.
131. 129 not 130
TOTAL before de-duplication Nov 2012: 40993
May 2014: 6818
TOTAL: 47812
TOTAL after de-dupe 24310
Appendix 3. Information for extraction to proforma
Bibliographic details of primary paper: Author, title of study, year
Details of index test
• Language of test
• Was any translation of MMSE validated? (yes/no)
• MMSE Diagnostic Threshold
• Was the threshold pre-specified? (yes/no)
• Who administered the MMSE?
• Was index test conducted without knowledge of reference standard results?
• Could the conduct or interpretation of the index test have introduced bias?
• Notes on conduct of index test
Reference Standard
• Target condition
• What was the prevalence of dementia in the sample population?
• Who administered the reference standard?
• Reference Standard
• Was any attempt made to subtype dementia categories?
• Was reference standard interpreted without knowledge of index test results?
Study population
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• Country of study
• Number of participants
• Number of participants in analysis
• Patient sampling
• Consecutive/random sampling (yes/no)
• Did the study avoid inappropriate exclusions? (yes/no)
• Could the selection process have introduced bias? (yes/no)
• Comments on sampling, inclusions and exclusions
• What is the patient population?
◦ Unselected community
◦ Community with possible memory problem
◦ Unselected primary care
◦ Primary care with possible memory problem
• Age
• Gender (% female participants)
• Years of education
• Social class
• Comorbidity
Patient flow and timing
• What was the interval between index test and reference standard?
• Did all participants receive a reference standard?
• Did all participants receive the same reference standard?
• Notes of reference standard procedure.
• Were all participants included in the analysis?
• Were those not included in the analysis fully accounted for?
• Notes on patient flow and timing
• Other characteristics (e.g. ApoE status)
• Attrition and missing data
Appendix 4. Assessment of methodological quality QUADAS-2
Domain Patient selection Index test Reference standard Flow and timing
Description Describe methods of pa-
tient selection: Describe
included patients (prior
testing, presentation, in-
tended use of index test
and setting)
Describe the index test
and how it was con-
ducted and interpreted
Describe the reference
standard and how it
was conducted and in-
terpreted
Describe any patients
who did not receive the
index test(s) or reference
standard or who were
excluded from the 2 x
2 table (refer to flow
diagram): Describe the
time interval and any in-
terventions between in-
dex test(s) and reference
standard
Signalling questions
(yes/no/unclear)
Was a consecutive or ran-
dom sample of patients
enrolled?
Were the index test re-
sults interpreted without
knowledge of the results
Is the reference standard
likely to correctly classify
the target condition?
Was there an appropri-
ate interval between in-
dex test(s) and reference
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of the reference stan-
dard?
standard?
Was a case-control de-
sign avoided?
If a threshold was used,
was it pre-specified?
Were the reference stan-
dard results interpreted
without knowledge of
the results of the index
test?
Did all patients receive a
reference standard?
Did the study avoid in-
appropriate exclusions?
Did all patients receive
the same reference stan-
dard?
Were all patients in-
cluded in the analysis?
Risk of bias:
(High/low/ unclear)
Could the selection of
patients have introduced
bias?
Could the conduct or in-
terpretation of the in-
dex test have introduced
bias?
Could the reference stan-
dard, its conduct, or its
interpretation have in-
troduced bias?
Could the patient flow
have introduced bias?
Concerns regarding ap-
plicability:
(High/low/ unclear)
Are there concerns that
the included patients do
not match the review
question?
Are there concerns that
the index test, its con-
duct, or interpretation
differ from the review
question?
Are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
-
Appendix 5. Anchoring statements for quality assessment of Mini Mental State Examination
(MMSE) diagnostic studies
We provide some core anchoring statements for quality assessment of diagnostic test accuracy reviews of the MMSE in dementia.
These statements are designed for use with the QUADAS-2 tool and were derived during a two day, multidisciplinary focus group in
2010. If a QUADAS-2 signalling question for a specific domain is answered ’yes’ then the risk of bias can be judged to be ’low’. If a
question is answered ’no’ this indicates a risk of potential bias. The focus group was tasked with judging the extent of the bias for each
domain. During this process it became clear that certain issues were key to assessing quality, whilst others were important to record
but less important for assessing overall quality. To assist, we describe a ’weighting’ system. Where an item is weighted ’high risk’ then
that section of the QUADAS-2 results table is judged to have a high potential for bias if a signalling question is answered ’no’. For
example in dementia diagnostic test accuracy studies, ensuring that clinicians performing dementia assessment are blinded to results
of index test is fundamental. If this blinding was not present then the item on reference standard should be scored ’high risk of bias’,
regardless of the other contributory elements. Where an item is weighted ’low risk’ then it is judged to have a low potential for bias
if a signalling question for that section of the QUADAS-2 results table is answered ’no’. Overall bias will be judged on whether other
signalling questions (with a high risk of bias) for the same domain are also answered ’no’.
In assessing individual items, the score of unclear should only be given if there is genuine uncertainty. In these situations review authors
will contact the relevant study teams for additional information.
Anchoring statements to assist with assessment for risk of bias
Domain 1: Patient selection
Risk of bias: could the selection of patients have introduced bias? (high/low/unclear)
Was a consecutive or random sample of patients enrolled?
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Where sampling is used, the methods least likely to cause bias are consecutive sampling or random sampling, which should be stated,
described or both. Non-random sampling or sampling based on volunteers is more likely to be at high risk of bias.
Weighting: high risk of bias
Was a case-control design avoided?
Case-control study designs have a high risk of bias, but sometimes they are the only studies available especially if the index test is
expensive or invasive. Nested case-control designs (systematically selected from a defined population cohort) are less prone to bias
but they will still narrow the spectrum of patients that receive the index test. Study designs (both cohort and case-control) that may
also increase bias are those designs where the study team deliberately increases or decreases the proportion of subjects with the target
condition, for example a population study may be enriched with extra dementia subjects from a secondary care setting.
Weighting: High risk of bias
Did the study avoid inappropriate exclusions?
The study will be automatically graded as unclear if exclusions are not detailed (pending contact with study authors). Where exclusions
are detailed, the study will be graded as ’low risk’ if exclusions are felt to be appropriate by the review authors. Certain exclusions
common to many studies of dementia are: medical instability; terminal disease; alcohol/substance misuse; concomitant psychiatric
diagnosis; other neurodegenerative condition. However if ’difficult to diagnose’ groups are excluded this may introduce bias, so exclusion
criteria must be justified. For a community sample we would expect relatively few exclusions. Post hoc exclusions will be labelled ’high
risk’ of bias.
Weighting: high risk of bias
Applicability: are there concerns that the included patients do not match the review question? (high/low/unclear)
The included patients should match the intended population as described in the review question. If not already specified in the review
inclusion criteria, setting will be particularly important - the review authors should consider population in terms of symptoms; pre-
testing; potential disease prevalence. Studies that use very selected subjects or subgroups will be classified as low applicability, unless
they are intended to represent a defined target population, for example, people with memory problems referred to a specialist and
investigated by lumbar puncture.
Domain 2: Index Test
Risk of bias: could the conduct or interpretation of the MMSE have introduced bias? (high/low/unclear)
Were the MMSE results interpreted without knowledge of the reference standard?
Terms such as ’blinded’ or ’independently and without knowledge of ’ are sufficient and full details of the blinding procedure are not
required. This item may be scored as ’low risk’ if explicitly described or if there is a clear temporal pattern to the order of testing
that precludes the need for formal blinding i.e. all MMSE assessments were performed before the dementia assessment. As most
neuropsychological tests are administered by a third party, knowledge of dementia diagnosis may influence their ratings; tests that are
self-administered, for example using a computerised version, may have less risk of bias.
Weighting: High risk
Were the MMSE cut points pre-specified?
For neuropsychological scales there is usually a cut point above which subjects are classified as ’test positive’; this may also be referred
to as threshold; clinical cut-off or dichotomisation point. Different cut points are used in different populations. A study is classified
at higher risk of bias if the authors define the optimal cut-off post hoc based on their own study data. Certain papers may use an
alternative methodology for analysis that does not use thresholds, and these papers should be classified as not applicable.
Weighting: low risk
Were sufficient data on MMSE application given for the test to be repeated in an independent study?
Particular points of interest include method of administration (for example self-completed questionnaire versus direct questioning
interview); nature of informant; language of assessment. If a novel form of the index test is used, for example a translated questionnaire,
details of the scale should be included and a reference given to an appropriate descriptive text, and there should be evidence of validation.
Weighting: low risk
Applicability: are there concerns that the MMSE, its conduct, or interpretation differ from the review question? (high/low/
unclear)
Variations in the length, structure, language and administration of the index test may all affect applicability if they vary from those
specified in the review question.
Domain 3: Reference Standard
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Risk of bias: could the reference standard, its conduct, or its interpretation have introduced bias? (high/low/unclear)
Is the reference standard likely to correctly classify the target condition?
Commonly used international criteria to assist with clinical diagnosis of dementia include those detailed in DSM-IV and ICD-10.
Criteria specific to dementia subtypes include but are not limited to NINCDS-ADRDA criteria for Alzheimer’s dementia; McKeith
criteria for Lewy Body dementia; Lund criteria for frontotemporal dementias; and the NINDS-AIREN criteria for vascular dementia.
Where the criteria used for assessment is not familiar to the review authors and the Cochrane Dementia and Cognitive Improvement
group this item should be classified as ’high risk of bias’.
Weighting: high risk
Were the reference standard results interpreted without knowledge of the results of the MMSE?
Terms such as ’blinded’ or ’independent’ are sufficient, and full details of the blinding procedure are not required. This may be scored
as ’low risk’ if explicitly described or if there is a clear temporal pattern to order of testing i.e. all dementia assessments performed before
[neuropsychological test] testing.
Informant rating scales and direct cognitive tests present certain problems. It is accepted that informant interview and cognitive testing is
a usual component of clinical assessment for dementia, however specific use of the scale under review in the clinical dementia assessment
should be scored as high risk of bias.
Weighting: high risk
Was sufficient information on the method of dementia assessment given for the assessment to be repeated in an independent study?
Particular points of interest for dementia assessment include the training/expertise of the assessor; and whether additional information
was available to inform the diagnosis (e.g. neuroimaging; other neuropsychological test results), and whether this was available for all
participants.
Weighting: variable risk, but high risk if method of dementia assessment not described
Applicability: are there concerns that the target condition as defined by the reference standard does not match the review
question? (high/low/unclear)
There is the possibility that some methods of dementia assessment, although valid, may diagnose a far smaller or larger proportion of
subjects with disease than in usual clinical practice. In this instance the item should be rated poor applicability.
Domain 4: Patient flow and timing (n.b. refer to, or construct, a flow diagram)
Risk of bias: could the patient flow have introduced bias? (high/low/unclear)
Was there an appropriate interval between the MMSE and reference standard?
For a cross-sectional study design, there is potential for the subject to change between assessments, however dementia is a slowly
progressive disease, which is not reversible. The ideal scenario would be a same day assessment, but longer periods of time (for example,
several weeks or months; and up to six months) are unlikely to lead to a high risk of bias.
Weighting: low risk
Did all subjects receive the same reference standard?
There may be scenarios where subjects who score ’test positive’ on the index test have a more detailed assessment for the target condition.
Where dementia assessment (or reference standard) differs between subjects this should be classified as high risk of bias.
Weighting: high risk
Were all subjects included in the final analysis?
Drop outs (and missing data) should be accounted for. Attrition that is higher than expected (compared to other similar studies) should
be treated as a high risk of bias.
Weighting: high risk
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Data extraction
We planned to extract data on study characteristics and quality to a study-specific pro forma. However, we finally entered the data
directly into RevMan because the number of studies that were eligible for inclusion was so large that we wanted to avoid any possibility
of introducing errors in transcribing data from one file or format to another (RevMan 2014). At least two senior authors worked
together in real time to perform data entry and check the transcription to avoid human error.
Analysis
We anticipated that the target conditionwould comprise two categories: (1) dementia (all-cause) and (2) dementia subtypes (Alzheimer’s,
vascular, Lewy body, frontotemporal), but our included studies only reported the all-cause dementia outcome, so we only performed
meta-analysis with this as the target condition.
Sensitivity analyses
We planned to perform sensitivity analysis to determine the effect of excluding studies that we deemed to be at high risk of bias.
However, as studies were generally at low risk of bias - no study had more than two of four QUADAS-2 items assessed as having a high
risk of bias - we did not do this as we did not pre-specify a point at which we would deem a study to be at overall ’high risk of bias’.
Heterogeneity
Wedid not investigate heterogeneity in test accuracy by education because this was poorly reported.We could not examine heterogeneity
by mean MMSE score because the models were unstable.
I N D E X T E R M S
Medical Subject Headings (MeSH)
AlzheimerDisease [diagnosis]; CommunityHealth Services; Dementia [∗diagnosis]; Dementia, Vascular [diagnosis]; LewyBodyDisease
[diagnosis]; Mental Status Schedule; Neuropsychological Tests [∗standards]; Primary Health Care; Randomized Controlled Trials as
Topic
MeSH check words
Aged; Humans
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